10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 0-16244

VEECO INSTRUMENTS INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware	11-2989601
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)
Terminal Drive Plainview, New York	11803
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code:

(516) 677-0200

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	VECO	The NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).Yes ☒  No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company ☐
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐  No ☒

As of August 1, 2023, there were 56,345,525 shares of the registrant’s common stock outstanding.

VEECO INSTRUMENTS INC.

INDEX

Safe Harbor Statement	1
PART I—FINANCIAL INFORMATION	4
Item 1. Financial Statements	4
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	30
Item 3. Quantitative and Qualitative Disclosures about Market Risk	38
Item 4. Controls and Procedures	39
PART II—OTHER INFORMATION	39
Item 1. Legal Proceedings	39
Item 1A. Risk Factors	40
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	40
Item 3. Defaults Upon Senior Securities	41
Item 4. Mine Safety Disclosures	41
Item 5. Other Information	41
Item 6. Exhibits	42
SIGNATURES	43

Safe Harbor Statement

This quarterly report on Form 10-Q (the “Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Discussions containing such forward-looking statements may be found in Part I - Items 1, 2, and 3 hereof, as well as within this Report generally. In addition, when used in this Report, the words “believes,” “anticipates,” “expects,” “estimates,” “targets,” “plans,” “intends,” “will,” and similar expressions related to the future are intended to identify forward-looking statements. All forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from projected results.

In addition, the preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates and assumptions are based on knowledge of current events, including the potential impact of the COVID-19 pandemic on our business, and planned actions to be undertaken in the future, they may ultimately differ from actual results. Operating results for the three and six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023. All estimates and assumptions are subject to a number of risks and uncertainties that could cause actual results to differ materially from these estimates and assumptions.

The risks and uncertainties of Veeco Instruments Inc. (together with its consolidated subsidiaries, “Veeco,” the “Company,” “we,” “us,” and “our,” unless the context indicates otherwise) include, without limitation, those set forth under the heading “Risk Factors” in Part 1, Item 1A of our 2022 Form 10-K, and the following:

Risks Related to Our Business and Industry

● Changes in U.S. trade policy and export controls and ongoing trade disputes between the U.S. and China have adversely affected, and may continue to adversely affect, our business, results of operations, and financial condition;

● Unfavorable market conditions have adversely affected, and may continue to adversely affect, our operating results;

● We face significant competition;

● We operate in industries characterized by rapid technological change;

● Certain of our sales are dependent on the demand for consumer electronic products and automobiles, which can experience significant volatility;

● The effects of the COVID-19 pandemic have strained and have negatively impacted our businesses and operations, and the duration and extent to which COVID-19 may impact our future results of operations and overall financial performance remains uncertain;

● We have a concentrated customer base, located primarily in a limited number of regions, which operates in highly concentrated industries;

● The cyclicality of the industries we serve directly affects our business;

● Our failure to estimate customer demand accurately could result in inventory obsolescence, liabilities to our suppliers for products no longer needed, and manufacturing interruptions or delays which could affect our ability to meet customer demand;

1

● We rely on a limited number of suppliers, some of whom are our sole source for particular components;

● Our failure to successfully manage our outsourcing activities or failure of our outsourcing partners to perform as anticipated could adversely affect our results of operations;

● The timing of our orders, shipments, and revenue recognition may cause our quarterly operating results to fluctuate significantly;

● Our sales cycle is long and unpredictable;

● Our backlog is subject to customer cancellation or modification which could result in decreased sales, increased inventory obsolescence, and liabilities to our suppliers for products no longer needed;

● We are exposed to risks associated with business combinations, acquisitions, strategic investments and divestitures;

Risks Associated with Operating a Global Business

● We are exposed to risks of operating businesses outside the United States;

● We may be unable to obtain required export licenses for the sale of our products;

● We are exposed to various risks associated with global regulatory requirements;

Risks Related to Intellectual Property and Cybersecurity

● Disruptions in our information technology systems or data security incidents could result in significant financial, legal, regulatory, business, and reputational harm to us;

● We may be unable to effectively enforce and protect our intellectual property rights;

● We may be subject to claims of intellectual property infringement by others;

Financial, Accounting, and Capital Markets Risks

● Our operating results may be adversely affected by tightening credit markets;

● We are subject to foreign currency exchange risks;

● We may be required to take impairment charges on assets;

● Changes in accounting pronouncements or taxation rules, practices, or rates may adversely affect our financial results;

● The agreements governing our current debt facilities, including our 3.50% Convertible Senior Notes due 2025 (the “2025 Notes”), our 3.75% Convertible Senior Notes due 2027 (the “2027 Notes”), and our 2.875% Convertible Senior Notes due 2029 (the “2029 Notes”) (the 2025 Notes, 2027 Notes, and 2029 Notes, together, the “Notes”), and our revolving credit facility (the “Credit Facility”), contains certain restrictions, covenants and repurchase provisions that may limit our ability to raise the funds necessary to meet our working capital needs, which may include the cash conversion of the Notes or repurchase of the Notes for cash upon a fundamental change;

2

● Issuance of our common stock, if any, upon conversion of the Notes, as well as the capped call transactions and the hedging activities of the option counterparties, may impair or reduce our ability to utilize our foreign tax credits or our research and development credits carryforwards in the future;

● The capped call transactions may affect the value of the 2027 Notes and our common stock;

General Risk Factors

● The price of our common shares is volatile and could decrease;

● Our inability to attract, retain, and motivate employees could have a material adverse effect on our business;

● We are subject to risks of non-compliance with environmental, health, and safety regulations and sustainability requirements;

● We are exposed to risks associated with the increased attention by our stakeholders to environmental, social and governance (“ESG”) matters; and

● We have adopted certain measures that may have anti-takeover effects which may make an acquisition of our Company by another company more difficult.

Consequently, such forward looking statements and estimates should be regarded solely as the current plans and beliefs of Veeco. We do not undertake any obligation to update any forward looking statements to reflect future events or circumstances after the date of such statements.

3

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

Veeco Instruments Inc. and Subsidiaries

Consolidated Balance Sheets

(in thousands, except share amounts)

	June 30,		December 31,
	2023		2022
Assets	(unaudited)
Current assets:
Cash and cash equivalents	$	180,524	$	154,925
Restricted cash		437		547
Short-term investments		105,875		147,488
Accounts receivable, net		130,140		124,221
Contract assets		20,490		16,507
Inventories		244,470		206,908
Prepaid expenses and other current assets		27,218		18,305
Total current assets		709,154		668,901
Property, plant, and equipment, net		111,993		107,281
Operating lease right-of-use assets		25,611		26,467
Intangible assets, net		48,192		23,887
Goodwill		214,964		181,943
Deferred income taxes		115,314		116,349
Other assets		3,219		3,355
Total assets	$	1,228,447	$	1,128,183
Liabilities and stockholders' equity
Current liabilities:
Accounts payable	$	63,212	$	52,049
Accrued expenses and other current liabilities		61,823		56,031
Customer deposits and deferred revenue		156,700		127,223
Income taxes payable		563		2,432
Current portion of long-term debt		—		20,169
Total current liabilities		282,298		257,904
Deferred income taxes		6,878		1,285
Long-term debt		274,335		254,491
Long-term operating lease liabilities		32,838		33,581
Other liabilities		19,498		3,098
Total liabilities		615,847		550,359
Stockholders' equity:
Preferred stock, $0.01 par value; 500,000 shares authorized; no shares issued and outstanding.		—		—
Common stock, $0.01 par value; 120,000,000 shares authorized; 56,337,933 shares issued and outstanding at June 30, 2023 and 51,660,409 shares issued and outstanding at December 31, 2022		564		517
Additional paid-in capital		1,189,051		1,078,180
Accumulated deficit		(578,380)		(501,801)
Accumulated other comprehensive income		1,365		928
Total stockholders' equity		612,600		577,824
Total liabilities and stockholders' equity	$	1,228,447	$	1,128,183

See accompanying Notes to the Consolidated Financial Statements.

4

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Operations

(in thousands, except per share amounts)

(unaudited)

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
Net sales	$	161,641	$	163,999	$	315,145	$	320,425
Cost of sales		94,131		99,732		185,618		190,146
Gross profit		67,510		64,267		129,527		130,279
Operating expenses, net:
Research and development		27,384		26,016		54,945		50,133
Selling, general, and administrative		23,822		22,950		46,449		45,844
Amortization of intangible assets		2,123		2,505		4,235		5,009
Other operating expense (income), net		493		(27)		404		(47)
Total operating expenses, net		53,822		51,444		106,033		100,939
Operating income		13,688		12,823		23,494		29,340
Interest income		2,420		213		4,494		302
Interest expense		(3,052)		(2,848)		(5,928)		(5,740)
Other income (expense), net		(97,091)		—		(97,091)		—
Income (loss) before income taxes		(84,035)		10,188		(75,031)		23,902
Income tax expense (benefit)		1,285		533		1,548		917
Net income (loss)	$	(85,320)	$	9,655	$	(76,579)	$	22,985
Income (loss) per common share:
Basic	$	(1.61)	$	0.19	$	(1.48)	$	0.46
Diluted	$	(1.61)	$	0.18	$	(1.48)	$	0.43
Weighted average number of shares:
Basic		52,861		49,697		51,764		49,702
Diluted		52,861		59,455		51,764		59,521

See accompanying Notes to the Consolidated Financial Statements.

5

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income

(in thousands)

(unaudited)

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
Net income (loss)	$	(85,320)	$	9,655	$	(76,579)	$	22,985
Other comprehensive income (loss), net of tax:
Unrealized gain (loss) on available-for-sale securities		—		(224)		470		(1,043)
Change in currency translation adjustments		(39)		(48)		(33)		(51)
Total other comprehensive income (loss), net of tax		(39)		(272)		437		(1,094)
Total comprehensive income (loss)	$	(85,359)	$	9,383	$	(76,142)	$	21,891

See accompanying Notes to the Consolidated Financial Statements.

6

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

	Six months ended June 30,
	2023		2022
Cash Flows from Operating Activities
Net income (loss)	$	(76,579)	$	22,985
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization		12,435		12,749
Non-cash interest expense		514		477
Deferred income taxes		778		(18)
Share-based compensation expense		14,959		10,759
Loss on extinguishment of debt		97,091		—
Provision for bad debts		490		—
Changes in operating assets and liabilities:
Accounts receivable and contract assets		(10,145)		(16,346)
Inventories		(44,540)		(5,873)
Prepaid expenses and other current assets		(5,633)		8,231
Accounts payable and accrued expenses		9,099		(17,613)
Customer deposits and deferred revenue		29,048		11,424
Income taxes receivable and payable, net		(1,869)		(263)
Other, net		(513)		1,657
Net cash provided by (used in) operating activities		25,135		28,169
Cash Flows from Investing Activities
Capital expenditures		(10,836)		(15,420)
Acquisition of businesses, net of cash acquired		(30,373)		—
Proceeds from the sale of investments		112,895		23,335
Payments for purchases of investments		(69,320)		(33,876)
Net cash provided by (used in) investing activities		2,366		(25,961)
Cash Flows from Financing Activities
Proceeds from issuance of 2029 Notes, net of issuance costs		223,202		—
Extinguishment of Convertible Notes		(218,991)		—
Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan		2,619		2,129
Restricted stock tax withholdings		(8,801)		(7,115)
Net cash provided by (used in) financing activities		(1,971)		(4,986)
Effect of exchange rate changes on cash and cash equivalents		(41)		(51)
Net increase (decrease) in cash, cash equivalents, and restricted cash		25,489		(2,829)
Cash, cash equivalents, and restricted cash - beginning of period		155,472		120,472
Cash, cash equivalents, and restricted cash - end of period	$	180,961	$	117,643
Supplemental Disclosure of Cash Flow Information
Interest paid	$	6,628	$	5,037
Income taxes paid		2,983		1,083
Non-cash activities
Capital expenditures included in accounts payable and accrued expenses		3,938		6,464
Net transfer of inventory to property, plant and equipment		4,328		237
Right-of-use assets obtained in exchange for lease obligations		630		258

See accompanying Notes to the Consolidated Financial Statements.

7

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

(unaudited)

Note 1 — Basis of Presentation

The accompanying unaudited Consolidated Financial Statements of Veeco have been prepared in accordance with U.S. GAAP as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 270 for interim financial information and with the instructions to Rule 10-01 of Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements as the interim information is an update of the information that was presented in Veeco’s most recent annual financial statements. For further information, refer to Veeco’s Consolidated Financial Statements and Notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2022 (“2022 Form 10-K”). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal, recurring nature.

Veeco reports interim quarters on a 13-week basis ending on the last Sunday of each quarter. The fourth quarter always ends on the last day of the calendar year, December 31. The 2023 interim quarters end on April 2, July 2, and October 1, and the 2022 interim quarters ended on April 3, July 3, and October 2. These interim quarters are reported as March 31, June 30, and September 30 in Veeco’s interim consolidated financial statements.

The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, actual results may differ from these estimates.

Revenue Recognition

Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, the Company estimates the amount of variable consideration and determines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another.

When there are separate units of accounting, the Company allocates revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items that are not sold separately, the Company estimates stand-alone selling prices generally using an expected cost plus margin approach.

Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in the Company’s facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed

8

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. The Company recognizes such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

In certain cases the Company’s contracts with customers contain a billing retention, which is billed by the Company and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets.

The Company recognizes revenue related to maintenance and service contracts over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or generally expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred since the expected amortization period is one year or less.

The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in cost of sales when the Company recognizes revenue for the related goods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue.

Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for the Company’s products may require a write down of inventory, which would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition.

9

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Note 2 — Income Per Common Share

Basic income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted income per share is calculated by dividing net income available to common shareholders by the weighted average number of shares used to calculate basic income per share plus the weighted average number of common share equivalents outstanding during the period. The dilutive effect of outstanding options to purchase common stock and share-based awards is considered in diluted income per share by application of the treasury stock method. The dilutive effect of performance share units is included in diluted income per common share if the performance targets have been achieved, or would have been achieved if the reporting date was the end of the contingency period. Finally, the Company includes the dilutive effect of shares issuable upon conversion of its Notes in the calculation of diluted income per share using the if-converted method. The Company has the option for the 2025 and 2027 Notes to settle the conversion value in any combination of cash or shares, and as such, the maximum number of shares issuable are included in the dilutive share count if the effect would be dilutive. The Company must settle the principal amount of the 2029 Notes in cash, and has the option to settle any excess of the conversion value over the principal amount in any combination of cash or shares. As such, the Company only includes the excess shares that may be issuable above the principal amount of the 2029 Notes in the dilutive share count, if the effect would be dilutive.

The computations of basic and diluted income per share for the three and six months ended June 30, 2023 and 2022 are as follows:

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands, except per share amounts)
Numerator:
Net income (loss)	$	(85,320)	$	9,655	$	(76,579)	$	22,985
Interest expense associated with convertible notes		—		1,273		—		2,546
Net income (loss) available to common shareholders	$	(85,320)	$	10,928	$	(76,579)	$	25,531
Denominator:
Basic weighted average shares outstanding		52,861		49,697		51,764		49,702
Effect of potentially dilutive share-based awards		—		816		—		877
Dilutive effect of convertible notes		—		8,942		—		8,942
Diluted weighted average shares outstanding		52,861		59,455		51,764		59,521
Net income per common share:
Basic	$	(1.61)	$	0.19	$	(1.48)	$	0.46
Diluted	$	(1.61)	$	0.18	$	(1.48)	$	0.43
Common share equivalents excluded from the diluted weighted average shares outstanding since the Company incurred a net loss and their effect would be antidilutive		838		N/A		674		N/A
Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive		743		987		763		645
Potential shares to be issued for settlement of the convertible notes excluded from the diluted calculation as their effect would be antidilutive		8,868		6,025		11,722		6,025

10

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Note 3 — Business Combination

Epiluvac

On January 31, 2023, the Company acquired Epiluvac AB, a privately held manufacturer of chemical vapor deposition (CVD) epitaxy systems that enable silicon carbide (SiC) applications in the electric vehicle market. This acquisition is expected to accelerate penetration into the emerging, high-growth SiC equipment market. The results of Epiluvac’s operations have been included in the consolidated financial statements since the date of acquisition.

The acquisition date fair value of the consideration totaled $56.4 million, net of cash acquired, which consisted of the following:

	Acquisition Date
	(January 31, 2023)
	(in thousands)
Cash paid, net of cash acquired	$	30,373
Contingent consideration		26,055
Acquisition date fair value	$	56,428

The purchase agreement included performance milestones that, if achieved, could trigger additional payments to the original selling shareholders. The aggregate fair value of the contingent consideration arrangement at the acquisition date was $26.1 million. During the three months ended June 30, 2023, the Company recognized approximately $0.3 million of additional contingent consideration, for total contingent consideration of $26.4 million as of June 30, 2023, of which $9.8 million was included in “Accrued expenses and other current liabilities” and $16.6 million was included within “Other liabilities” on the Consolidated Balance Sheet as of June 30, 2023. The contingent arrangements include payments up to $15.0 million based on the timely completion of certain defined milestones tied to strategic targets, and up to $20.0 million based on the percentage of orders received during the defined Earn-out period. The Earn-out period is four years after the closing date of the acquisition, or earlier if certain conditions are met.

The Company estimated the fair value of the contingent consideration by assigning probabilities and discount factors to each of the various defined performance milestones, while using a Monte-Carlo simulation model to determine the most likely outcome for payments to be based on value of orders received. These fair value measurements are based on significant inputs not observable in the market and thus represent a Level 3 measurement as defined in ASC 820. The discount rate used was 5.54% for the strategic target and order value related contingent payments. The rate was determined based on the nature of the milestone, the risks and uncertainties involved and the time period until the milestone was measured. The determination of the various probabilities and discount factors is highly subjective, requires significant judgment and is influenced by a number of factors, including the adoption of SiC technology. While the use of SiC is expected to grow in the near future, it is difficult to predict the rate at which SiC will be adopted by the market and thus would impact the sales of our equipment.

11

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date:

	Acquisition Date
	(January 31, 2023)
	(in thousands)
Accounts receivable	$	247
Inventories		391
Prepaid expense and other current assets		381
Property, plant, and equipment		736
Intangible assets		28,540
Total identifiable assets acquired		30,295
Accounts payable and accrued expenses		656
Customer deposits and deferred revenue		429
Deferred income taxes		5,723
Other liabilities		80
Total liabilities assumed		6,888
Net identifiable assets acquired		23,407
Goodwill		33,021
Net assets acquired	$	56,428

The gross contractual value of the acquired accounts receivable is the amount expected to be collected by the Company, and therefore is also considered its fair value. Goodwill generated from the acquisition is primarily attributed to expected synergies from future growth and strategic advantages provided through the expansion of product offerings as well as assembled workforce and is not expected to be deductible for income tax purposes.

The classes of intangible assets acquired, and the estimated useful life of each class is presented in the table below:

	Acquisition Date
	(January 31, 2023)
	Amount		Useful life
	(in thousands)
Technology	$	28,020	15	years
Customer relationships		460	5	years
Backlog		60	1.5	years
Intangible assets acquired	$	28,540

The Company determined the estimated fair value of the identifiable intangible assets based on various factors including cost, discounted cash flow, income method, loss-of-revenue/income method, and relief-from-royalty method in determining the purchase price allocation.

For the three and six months ended June 30, 2023, the Company incurred approximately $0.2 million and $0.9 million, respectively, of acquisition related costs, included within “Selling, general, and administrative” in the Consolidated Statement of Operations. Epiluvac’s results of operations were immaterial to the Company’s Consolidated Statement of Operations for the three and six months ended June 30, 2023. Additionally, the pro forma Consolidated Statement of Operations as if Epiluvac had been acquired as of January 1, 2022 would not be materially different from the Company’s actual Consolidated Statement of Operations for the three and six months ended June 30, 2023 or 2022.

12

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Note 4 — Assets

Investments

Short-term investments are generally classified as available-for-sale and reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income” in the Consolidated Balance Sheets. These securities may include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other operating expense (income), net” in the Consolidated Statements of Operations.

Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. Veeco classifies certain assets based on the following fair value hierarchy:

Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Veeco has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions or estimation methodologies could have a significant effect on the estimated fair value amounts.

13

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

The following table presents the portion of Veeco’s assets that were measured at fair value on a recurring basis at June 30, 2023 and December 31, 2022:

	Level 1		Level 2		Level 3		Total
	(in thousands)
June 30, 2023
Cash equivalents
Certificate of deposits and time deposits	$	57,432	$	—	$	—	$	57,432
Commercial paper		—		11,475		—		11,475
Money market cash		50,846		—		—		50,846
Total	$	108,278	$	11,475	$	—	$	119,753
Short-term investments
U.S. treasuries	$	12,041	$	—	$	—	$	12,041
Government agency securities		—		60,054		—		60,054
Corporate debt		—		13,020		—		13,020
Commercial paper		—		20,760		—		20,760
Total	$	12,041	$	93,834	$	—	$	105,875
December 31, 2022
Cash equivalents
Certificate of deposits and time deposits	$	61,135	$	—	$	—	$	61,135
Money market cash		405		—		—		405
Total	$	61,540	$	—	$	—	$	61,540
Short-term investments
U.S. treasuries	$	62,849	$	—	$	—	$	62,849
Government agency securities		—		27,366		—		27,366
Corporate debt		—		41,591		—		41,591
Commercial paper		—		15,682		—		15,682
Total	$	62,849	$	84,639	$	—	$	147,488

There were no transfers between fair value measurement levels during the three and six months ended June 30, 2023.

14

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

At June 30, 2023 and December 31, 2022, the amortized cost and fair value of available-for-sale securities consist of:

			Gross		Gross
	Amortized		Unrealized		Unrealized		Estimated
	Cost		Gains		Losses		Fair Value
	(in thousands)
June 30, 2023
U.S. treasuries	$	12,133	$	—	$	(92)	$	12,041
Government agency securities		60,262		—		(208)		60,054
Corporate debt		13,108		—		(88)		13,020
Commercial paper		20,760		—		—		20,760
Total	$	106,263	$	—	$	(388)	$	105,875
December 31, 2022
U.S. treasuries	$	63,331	$	—	$	(482)	$	62,849
Government agency securities		27,464		—		(98)		27,366
Corporate debt		42,006		—		(415)		41,591
Commercial paper		15,682		—		—		15,682
Total	$	148,483	$	—	$	(995)	$	147,488

Available-for-sale securities in a loss position at June 30, 2023 and December 31, 2022 consist of:

	Continuous Loss Position				Continuous Loss Position
	for Less than 12 Months				for 12 Months or More
			Gross				Gross
	Estimated		Unrealized		Estimated		Unrealized
	Fair Value		Losses		Fair Value		Losses
		(in thousands)
June 30, 2023
U.S. treasuries	$	4,681	$	(4)	$	7,361	$	(88)
Government agency securities		60,053		(208)		—		—
Corporate debt		8,312		(21)		4,708		(67)
Total	$	73,046	$	(233)	$	12,069	$	(155)
December 31, 2022
U.S. treasuries	$	39,791	$	(84)	$	23,057	$	(398)
Government agency securities		22,528		(86)		4,838		(12)
Corporate debt		19,693		(138)		21,898		(277)
Total	$	82,012	$	(308)	$	49,793	$	(687)

The contractual maturities of securities classified as available-for-sale at June 30, 2023 were as follows:

	June 30, 2023
	Amortized		Estimated
	Cost		Fair Value
		(in thousands)
Due in one year or less	$	99,537	$	99,192
Due after one year through two years		6,726		6,683
Total	$	106,263	$	105,875

15

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. There were no realized gains or losses, or unrealized losses from declines in fair value that are other than temporary, for the six months ended June 30, 2023 and 2022.

Accounts Receivable

Accounts receivable is presented net of an allowance for doubtful accounts of $1.0 million and $0.7 million at June 30, 2023 and December 31, 2022 respectively. The Company considered its current expectations of future economic conditions when estimating its allowance for doubtful accounts.

Inventories

Inventories at June 30, 2023 and December 31, 2022 consist of the following:

	June 30,		December 31,
	2023		2022
	(in thousands)
Materials	$	152,494	$	134,940
Work-in-process		80,446		68,765
Finished goods		11,530		3,203
Total	$	244,470	$	206,908

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets primarily consist of supplier deposits, prepaid value-added tax, lease deposits, prepaid insurance, prepaid licenses, and other receivables. The Company had deposits with its suppliers of $13.4 million and $9.4 million at June 30, 2023 and December 31, 2022, respectively.

Property, Plant, and Equipment

Property, plant, and equipment at June 30, 2023 and December 31, 2022 consist of the following:

	June 30,		December 31,
	2023		2022
	(in thousands)
Land	$	5,061	$	5,061
Building and improvements		64,151		64,198
Machinery and equipment (1)		166,764		155,533
Leasehold improvements		55,008		54,764
Gross property, plant, and equipment		290,984		279,556
Less: accumulated depreciation and amortization		178,991		172,275
Net property, plant, and equipment	$	111,993	$	107,281

(1) Machinery and equipment also includes software, furniture and fixtures

For the three and six months ended June 30, 2023, depreciation expense was $4.0 million and $8.2 million, respectively, and $4.0 million and $7.7 million, respectively, for the comparable 2022 periods.

16

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Goodwill

Goodwill represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. The following table presents the changes in goodwill balances for the six months ended June 30, 2023:

	Gross carrying		Accumulated
	amount		impairment		Net amount
	(in thousands)
Balance at December 31, 2022	$	430,331	$	248,388	$	181,943
Acquisition		33,021		—		33,021
Balance at June 30, 2023	$	463,352	$	248,388	$	214,964

Intangible Assets

Intangible assets consist of purchased technology, customer relationships, patents, trademarks and tradenames, licenses, and backlog, and are initially recorded at fair value. Long-lived intangible assets are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or amortized on a straight-line basis if such pattern cannot be reliably determined. The Company continues to assess potential triggering events related to the value of its intangible assets and concluded that there were no indicators of impairment during the three and six months ended June 30, 2023.

The components of purchased intangible assets were as follows:

	June 30, 2023						December 31, 2022
			Accumulated						Accumulated
	Gross		Amortization				Gross		Amortization
	Carrying		and		Net		Carrying		and		Net
	Amount		Impairment		Amount		Amount		Impairment		Amount
	(in thousands)
Technology	$	355,928	$	319,420	$	36,508	$	327,908	$	316,918	$	10,990
Customer relationships		146,925		136,528		10,397		146,465		135,415		11,050
Trademarks and tradenames		30,910		29,666		1,244		30,910		29,063		1,847
Other		3,746		3,703		43		3,686		3,686		—
Total	$	537,509	$	489,317	$	48,192	$	508,969	$	485,082	$	23,887

Other intangible assets primarily consist of patents, licenses, and backlog.

17

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Note 5 — Liabilities

Accrued Expenses and Other Current Liabilities

The components of accrued expenses and other current liabilities at June 30, 2023 and December 31, 2022 consist of:

	June 30,		December 31,
	2023		2022
	(in thousands)
Payroll and related benefits	$	21,358	$	30,044
Contingent consideration		9,791		—
Warranty		8,577		8,601
Operating lease liabilities		3,615		3,333
Interest		1,351		2,853
Professional fees		3,443		2,102
Sales, use, and other taxes		2,708		2,027
Other		10,980		7,071
Total	$	61,823	$	56,031

Warranty

Warranties are typically valid for one year from the date of system final acceptance. The Company estimates the costs that may be incurred under the warranty which are determined by analyzing specific product and historical configuration statistics and regional warranty support costs and are affected by product failure rates, material usage, and labor costs incurred in correcting product failures during the warranty period. Unforeseen component failures or exceptional component performance can also result in changes to warranty costs. Changes in product warranty reserves for the six months ended June 30, 2023 include:

		(in thousands)
Balance - December 31, 2022	$	8,601
Warranties issued		3,084
Addition from Epiluvac acquisition		49
Consumption of reserves		(3,484)
Changes in estimate		327
Balance - June 30, 2023	$	8,577

Customer Deposits and Deferred Revenue

Customer deposits totaled $136.6 million and $110.2 million at June 30, 2023 and December 31, 2022, respectively. Deferred revenue represents amounts billed, other than deposits, in excess of the revenue that can be recognized on a particular contract at the balance sheet date. Changes in deferred revenue were as follows:

	(in thousands)
Balance - December 31, 2022	$	16,990
Deferral of revenue		8,241
Recognition of unearned revenue		(5,111)
Balance - June 30, 2023	$	20,120

18

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

As of June 30, 2023, the Company has approximately $274.8 million of remaining performance obligations on contracts with an original estimated duration of one year or more, of which approximately 66% is expected to be recognized within one year, with the remaining amounts expected to be recognized between one to three years. The Company has elected to exclude disclosures regarding remaining performance obligations that have an original expected duration of one year or less.

Convertible Senior Notes

2023 Notes

On January 10, 2017, the Company issued $345.0 million of 2.70% convertible senior unsecured notes due 2023 (the “2023 Notes”). The Company received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The 2023 Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The 2023 Notes had a maturity date of January 15, 2023, unless earlier purchased by the Company, redeemed, or converted.

On May 18, 2020, in connection with the completion of a private offering of $125.0 million aggregate principal amount of 3.75% convertible senior notes due 2027 described below, the Company repurchased and retired approximately $88.3 million in aggregate principal amount of its outstanding 2023 Notes, with a carrying amount of $78.1 million, for approximately $81.2 million of cash.

Additionally, on November 11, 2020, the Company entered into a privately negotiated exchange agreement with a holder of its outstanding 2023 Notes, under which the Company agreed to retire $125.0 million in aggregate original principal amount of the 2023 Notes, with a carrying amount of $113.1 million, in exchange for the issuance of $132.5 million in aggregate principal amount of new 3.50% convertible senior notes due 2025 described below, which had a fair value that approximated the principal amount of new notes issued.

Finally, on November 5, 2021, the Company entered into a privately negotiated note purchase agreement with a holder of its outstanding 2023 Notes, under which the Company agreed to repurchase and retire approximately $111.5 million in aggregate original principal amount of the 2023 Notes, with a carrying amount of $105.5 million, for cash consideration of approximately $115.6 million, and approximately $1.0 million of accrued and unpaid interest.

The 2023 notes that remained outstanding matured on January 15, 2023 and were paid in cash and settled by the Company at that time.

2025 Notes

On November 17, 2020, as part of the privately negotiated exchange agreement described above, the Company issued $132.5 million of 3.50% convertible senior notes due 2025 (the “2025 Notes”). The 2025 Notes bear interest at a rate of 3.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2021. The 2025 Notes mature on January 15, 2025, unless earlier purchased by the Company, redeemed, or converted.

On May 19, 2023, in connection with the completion of a private offering of $230.0 million aggregate principal amount of 2.875% convertible senior notes due 2029 described below, the Company repurchased and retired approximately $106.0 million in aggregate principal amount of its outstanding 2025 Notes, with a carrying amount of $105.4 million, for approximately $106.0 million of cash and 0.7 million shares of the Company’s common stock. The Company accounted for the partial settlement of the 2025 Notes as an extinguishment, and as such, recorded a loss on

19

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

extinguishment of approximately $16.5 million for the three and six months ended June 30, 2023, which is included in the “Other income (expense), net” in the Consolidated Statements of Operations.

2027 Notes

On May 18, 2020, the Company completed a private offering of $125.0 million of 3.75% convertible senior notes due 2027 (the “2027 Notes”). The Company received net proceeds of approximately $121.9 million, after deducting underwriting discounts and fees and expenses payable by the Company. Additionally, the Company used approximately $10.3 million of cash to purchase capped calls, discussed below. The 2027 Notes bear interest at a rate of 3.75% per year, payable semiannually in arrears on June 1 and December 1 of each year, commencing on December 1, 2020. The 2027 Notes mature on June 1, 2027, unless earlier purchased by the Company, redeemed, or converted.

On May 19, 2023, in connection with the completion of a private offering of $230.0 million aggregate principal amount of 2.875% convertible senior notes due 2029 described below, the Company repurchased and retired approximately $100.0 million in aggregate principal amount of its outstanding 2027 Notes, with a carrying amount of $98.5 million, for approximately $92.8 million of cash and 3.8 million shares of the Company’s common stock. The Company accounted for the partial settlement of the 2027 Notes as an extinguishment, and as such, recorded a loss on extinguishment of approximately $80.6 million for the three and six months ended June 30, 2023, which is included in the “Other income (expense), net” in the Consolidated Statements of Operations.

2029 Notes

On May 19, 2023, the Company completed a private offering of $230.0 million of 2.875% convertible senior notes due 2029 (the “2029 Notes”). The Company received net proceeds of approximately $223.2 million, after deducting underwriting discounts and fees and expenses payable by the Company. Additionally, the Company used approximately $198.8 million of net proceeds from the offering to fund the cash portion of the 2025 Notes and 2027 Notes extinguishments described above and the remainder for general corporate purposes. The 2029 Notes bear interest at a rate of 2.875% per year, payable semiannually in arrears on June 1 and December 1 of each year, commencing on December 1, 2023. The 2029 Notes mature on June 1, 2029, unless earlier purchased by the Company, redeemed, or converted. The Company will settle any conversions of the 2029 Notes by paying cash up to the aggregate principal amount of the 2029 Notes to be converted, and paying or delivering either cash, shares of Company’s common stock, or a combination of cash and shares of common stock at the Company’s election, in respect of the remainder, if any, of the conversion obligation in excess of the aggregate principal amount of the 2029 Notes being converted.

The 2025 Notes, 2027 Notes, and 2029 Notes (collectively, the “Notes”) are unsecured senior obligations of Veeco and rank senior in right of payment to any of Veeco’s subordinated indebtedness; equal in right of payment to all of Veeco’s unsecured indebtedness that is not subordinated; effectively subordinated in right of payment to any of Veeco’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to all indebtedness and other liabilities (including trade payables) of Veeco’s subsidiaries.

The Notes are convertible at the option of the holders upon the satisfaction of specified conditions and during certain periods as described below. The initial conversion rates are 41.6667, 71.5372, and 34.21852 shares of the Company’s common stock per $1,000 principal amount of the 2025 Notes, 2027 Notes, and 2029 Notes, respectively, representing initial effective conversion prices of $24.00, $13.98, and $29.22 per share of common stock, respectively. The conversion rates may be subject to adjustment upon the occurrence of certain specified events.

Holders may convert all or any portion of their Notes, in multiples of one thousand dollar principal amount, at their option at any time prior to the close of business on the business day immediately preceding October 15, 2024, with

20

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

respect to the 2025 Notes, October 1, 2026, with respect to the 2027 Notes, and February 1, 2029 with respect to the 2029 Notes, only under the following circumstances:

(i) During any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

(ii) During the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollar principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;

(iii) If the Company calls any or all of applicable series of the Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or

(iv) Upon the occurrence of specified corporate events.

For the calendar quarter ended June 30, 2023, the last reported sales price of the common stock during the 30 consecutive trading days, based on the criteria outlined in (i) above, was greater than 130% of the conversion price of the 2027 Notes, and as such the 2027 Notes are convertible by the holders until September 30, 2023.

Holders may convert their Notes at any time, regardless of the foregoing circumstances, on October 15, 2024 with respect to the 2025 Notes, October 1, 2026, with respect to the 2027 Notes, and February 1, 2029, with respect to the 2029 Notes, until the close of business on the business day immediately preceding the respective maturity date.

The Notes are recorded as a single unit within liabilities in the consolidated balance sheets as the conversion features within the Notes are not derivatives that require bifurcation and the Notes do not involve a substantial premium. Transaction costs of $9.2 million, $1.9 million, $3.1 million, and $6.8 million incurred in connection with the issuance of the 2023 Notes, 2025 Notes, 2027 Notes, and 2029 Notes, respectively, were recorded as direct deductions from the related debt liabilities and recognized as non-cash interest expense using the effective interest method over the expected terms of the Notes.

The carrying value of the 2023 Notes, 2025 Notes, 2027 Notes, and 2029 Notes are as follows:

		June 30, 2023						December 31, 2022
		Principal Amount		Unamortized transaction costs		Net carrying value		Principal Amount		Unamortized debt discount/ transaction costs		Net carrying value
		(in thousands)
2023 Notes	$	—	$	—	$	—	$	20,173	$	(4)	$	20,169
2025 Notes		26,500		(149)		26,351		132,500		(990)		131,510
2027 Notes		25,000		(358)		24,642		125,000		(2,019)		122,981
2029 Notes		230,000		(6,657)		223,343		—		—		—
Net carrying value	$	281,500	$	(7,165)	$	274,335	$	277,673	$	(3,013)	$	274,660

21

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Total interest expense related to the 2023 Notes, 2025 Notes, 2027 Notes, and 2029 Notes is as follows:

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands)
Cash Interest Expense
Coupon interest expense - 2023 Notes	$	—	$	136	$	23	$	272
Coupon interest expense - 2025 Notes		737		1,159		1,896		2,318
Coupon interest expense - 2027 Notes		745		1,172		1,917		2,344
Coupon interest expense - 2029 Notes		753		—		753		—
Non-cash Interest Expense
Amortization of debt discount/transaction costs- 2023 Notes		—		24		4		48
Amortization of debt discount/transaction costs- 2025 Notes		77		114		194		226
Amortization of debt discount/transaction costs- 2027 Notes		70		101		175		202
Amortization of debt discount/transaction costs- 2029 Notes		141		—		141		—
Total Interest Expense	$	2,523	$	2,706	$	5,103	$	5,410

The Company determined the 2025 Notes, 2027 Notes, and 2029 Notes are Level 2 liabilities in the fair value hierarchy and had an estimated fair value at June 30, 2023 of $31.9 million, $49.3 million, and $257.0 million, respectively.

Capped Call Transactions

In connection with the offering of the 2027 Notes, on May 13, 2020, the Company entered into privately negotiated capped call transactions (the “Capped Call Transactions”), pursuant to capped call confirmations, covering the total principal amount of the 2027 Notes for an aggregate premium of $10.3 million. The Capped Call Transactions are expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of the 2027 Notes and/or offset any cash payments the Company is required to make in excess of the aggregate principal amount of converted 2027 Notes, as the case may be, with such reduction and/or offset subject to a cap based on the capped price of the Capped Call Transactions. The Capped Call Transactions exercise price is equal to the initial conversion price of the 2027 Notes, and the capped price of the Capped Call Transactions is approximately $18.46 per share and is subject to certain adjustments under the terms of the capped call confirmations.

The Capped Call Transactions are separate transactions entered into by the Company with the capped call counterparties, are not part of the terms of the 2027 Notes and do not change the holders’ rights under the 2027 Notes. Holders of the 2027 Notes do not have any rights with respect to the Capped Call Transactions. The cost of the Capped Call Transactions is not expected to be tax-deductible as the Company did not elect to integrate the Capped Call Transactions into the 2027 Notes for tax purposes. The Company used a portion of the net proceeds from the offering of the 2027 Notes to pay for the Capped Call Transactions, and the cost of the Capped Call Transactions was recorded as a reduction of the Company’s additional paid-in capital in the accompanying consolidated financial statements.

Revolving Credit Facility

On December 16, 2021, the Company entered into a loan and security agreement providing for a senior secured revolving credit facility in an aggregate principal amount of $150 million (the “Credit Facility”), including a $15 million letter of credit sublimit. The Credit Facility is guaranteed by the Company’s direct material U.S. subsidiaries, subject to customary exceptions. Borrowings under the Credit Facility are secured by a first-priority lien on substantially all of the assets of the Company, subject to customary exceptions. The Credit Facility has a term of five years, maturing on December 16, 2026, or earlier if certain liquidity measures are not met prior to the 2025 Notes maturing. Subject to certain conditions and the receipt of commitments from the lenders, the Loan and Security Agreement allows for revolving commitments under the Credit Facility to be increased by up to $75 million. The existing lenders under the Credit Facility are entitled, but not obligated, to provide such incremental commitments.

22

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Borrowings will bear interest at a floating rate which can be, at the Company’s option, either (a) an alternate base rate plus an applicable rate ranging from 0.50% to 1.25% or (b) a Secured Overnight Financing Rate (“SOFR”) (with a floor of 0.00%) for the specified interest period plus an applicable rate ranging from 1.50% to 2.25%, in each case, depending on the Company’s Secured Net Leverage Ratio (as defined in the Loan and Security Agreement). The Company will pay an unused commitment fee ranging from 0.25% to 0.35% based on unused capacity under the Credit Facility and the Company’s Secured Net Leverage Ratio. The Company may use the proceeds of borrowings under the Credit Facility to pay transaction fees and expenses, provide for its working capital needs and reimburse drawings under letters of credit and for other general corporate purposes.

The Loan and Security Agreement contains customary affirmative covenants for transactions of this type, including, among others, the provision of financial and other information to the administrative agent, notice to the administrative agent upon the occurrence of certain material events, preservation of existence, maintenance of properties and insurance, compliance with laws, including environmental laws, the provision of additional guarantees, and an affiliate transactions covenant, subject to certain exceptions. The Loan and Security Agreement contains customary negative covenants, including, among others, restrictions on the ability to merge and consolidate with other companies, incur indebtedness, refinance our existing convertible notes, grant liens or security interests on assets, make investments, acquisitions, loans, or advances, pay dividends, and sell or otherwise transfer assets.

The Loan and Security Agreement contains financial maintenance covenants that require the Borrower to maintain an Interest Coverage Ratio (as defined in the Loan and Security Agreement) of not less than 3.00 to 1.00, a Total Net Leverage Ratio (as defined in the Loan and Security Agreement) of not more than 4.50 to 1.00, and a Secured Net Leverage Ratio (as defined in the Loan and Security Agreement) of not more than 2.50 to 1.00, in each case, tested at the end of each fiscal quarter commencing with the fiscal quarter ending June 30, 2022. The Loan and Security Agreement also provides for a number of customary events of default, including, among others: payment defaults to the lenders; voluntary and involuntary bankruptcy proceedings; covenant defaults; material inaccuracies of representations and warranties; certain change of control events; material money judgments; and other customary events of default. The occurrence of an event of default could result in the acceleration of obligations and the termination of lending commitments under the Loan and Security Agreement.

No amounts were outstanding under the Credit Facility as of June 30, 2023 or December 31, 2022.

Other Liabilities

Other liabilities at June 30, 2023 and December 31, 2022 included (i) medical and dental benefits for former executives of $1.9 million and $2.0 million, respectively; (ii) asset retirement obligations of $0.9 million and $0.7 million, respectively; and (iii) contingent consideration of $16.6 million as of June 30, 2023.

Note 6 — Commitments and Contingencies

Leases

The Company’s operating leases primarily include real estate leases for properties used for manufacturing, R&D activities, sales and service, and administration, as well as certain equipment leases. Some leases may include options to renew for a period of up to 5 years, while others may include options to terminate the lease. The weighted average remaining lease term of the Company’s operating leases as of June 30, 2023 was 12 years, and the weighted average discount rate used in determining the present value of future lease payments was 5.6%.

23

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

The following table provides the maturities of lease liabilities at June 30, 2023:

	Operating
	Leases
	(in thousands)
Payments due by period:
2023	$	1,748
2024		4,599
2025		4,086
2026		4,060
2027		3,629
Thereafter		34,245
Total future minimum lease payments		52,367
Less: Imputed interest		(15,914)
Total	$	36,453
Reported as of June 30, 2023
Accrued expenses and other current liabilities	$	3,615
Long-term operating lease liabilities		32,838
Total	$	36,453

Operating lease cost for the three and six months ended June 30, 2023 were $1.2 million and $2.6 million, respectively, and $1.8 million and $3.7 million, respectively, for the comparable 2022 periods. Variable lease cost for the three and six months ended June 30, 2023 were $0.2 million and $0.5 million respectively, and $0.5 million and $1.0 million, respectively, for the comparable 2022 periods. Additionally, the Company has an immaterial amount of short-term leases. Operating cash outflows from operating leases for the six months ended June 30, 2023 and 2022 were $3.0 million and $3.8 million, respectively.

Receivable Purchase Agreement

The Company entered into a receivable purchase agreement with a financial institution to sell certain of its trade receivables from customers without recourse, up to $20.0 million at any point in time. Pursuant to this agreement, the Company sold $9.9 million of receivables during the three months ended June 30, 2023, all of which remained outstanding as of June 30, 2023 as defined in the receivable purchase agreement, and $10.1 million was available under the agreement for additional sales of receivables. The Company did not sell any receivables under this agreement for the six months ended June 30, 2022. The net sale of accounts receivable under the agreement is reflected as a reduction of accounts receivable in the Company’s Consolidated Balance Sheet at the time of sale and any fees for the sale of trade receivables were not material for the periods presented.

Purchase Commitments

Veeco has purchase commitments of $235.5 million at June 30, 2023, substantially all of which become due within one year.

Bank Guarantees

Veeco has bank guarantees and letters of credit issued by a financial institution on its behalf as needed. At June 30, 2023, outstanding bank guarantees and standby letters of credit totaled $19.3 million, and unused bank guarantees and letters of credit of $12.6 million were available to be drawn upon.

24

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Legal Proceedings

The Company is involved in various legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

Note 7 — Equity

Statement of Stockholders’ Equity

The following tables present the changes in Stockholders’ Equity:

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2022	51,660	$	517	$	1,078,180	$	(501,801)	$	928	$	577,824
Net income	—		—		—		8,741		—		8,741
Other comprehensive income (loss), net of tax	—		—		—		—		476		476
Share-based compensation expense	—		—		7,027		—		—		7,027
Net issuance under employee stock plans	33		—		(8,509)		—		—		(8,509)
Balance at March 31, 2023	51,693	$	517	$	1,076,698	$	(493,060)	$	1,404	$	585,559
Net income	—		—		—		(85,320)		—		(85,320)
Other comprehensive income (loss), net of tax	—		—		—		—		(39)		(39)
Share-based compensation expense	—		—		7,932		—		—		7,932
Partial extinguishment of 2025 and 2027 Notes	4,460		45		102,095						102,140
Net issuance under employee stock plans	185		2		2,326		—		—		2,328
Balance at June 30, 2023	56,338	$	564	$	1,189,051	$	(578,380)	$	1,365	$	612,600

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2021	50,653	$	507	$	1,116,921	$	(681,283)	$	1,483	$	437,628
Cumulative effect of change in accounting principle - adoption of ASU 2020-06	—		—		(56,801)		12,541		—		(44,260)
Net income	—		—		—		13,330		—		13,330
Other comprehensive income (loss), net of tax	—		—		—		—		(822)		(822)
Share-based compensation expense	—		—		4,481		—		—		4,481
Net issuance under employee stock plans	590		6		(6,793)		—		—		(6,787)
Balance at March 31, 2022	51,243	$	513	$	1,057,808	$	(655,412)	$	661	$	403,570
Net income	—		—		—		9,655		—		9,655
Other comprehensive income (loss), net of tax	—		—		—		—		(272)		(272)
Share-based compensation expense	—		—		6,278		—		—		6,278
Net issuance under employee stock plans	182		2		1,504		—		—		1,506
Balance at June 30, 2022	51,425	$	515	$	1,065,590	$	(645,757)	$	389	$	420,737

25

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Accumulated Other Comprehensive Income (“AOCI”)

The following table presents the changes in the balances of each component of AOCI, net of tax:

			Unrealized
			Gains (Losses)
	Foreign		on Available
	Currency		for Sale
	Translation		Securities		Total
	(in thousands)
Balance - December 31, 2022	$	1,773	$	(845)	$	928
Other comprehensive income (loss)		(33)		470		437
Balance - June 30, 2023	$	1,740	$	(375)	$	1,365

There were minimal reclassifications from AOCI into net income for the three and six months ended June 30, 2023 and 2022.

Note 8 — Share-based Compensation

Restricted share awards are issued to employees and to members of our board of directors that are subject to specified restrictions and a risk of forfeiture. The restrictions typically lapse over one to four years and may entitle holders to dividends and voting rights. Other types of share-based compensation include performance share awards, performance share units, and restricted share units (collectively with restricted share awards, “restricted shares”), as well as options to purchase common stock.

Share-based compensation expense was recognized in the following line items in the Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022:

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands)
Cost of sales	$	1,572	$	1,251	$	3,023	$	2,189
Research and development		2,568		1,863		4,657		3,120
Selling, general, and administrative		3,792		3,164		7,279		5,450
Total	$	7,932	$	6,278	$	14,959	$	10,759

For the six months ended June 30, 2023, equity activity related to stock options was as follows:

		Weighted
	Number of	Average
	Shares	Exercise Price
	(in thousands)
Balance - December 31, 2022	177	$	30.94
Expired	(62)		30.47
Balance - June 30, 2023	115		31.18

26

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

For the six months ended June 30, 2023, equity activity related to non-vested restricted shares and performance shares was as follows:

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
	(in thousands)
Balance - December 31, 2022	2,496	$	23.83
Granted	1,076		22.79
Performance award adjustments	183		10.59
Vested	(1,113)		16.47
Forfeited	(50)		28.01
Balance - June 30, 2023	2,592		25.66

Note 9 — Income Taxes

Income taxes are estimated for each of the jurisdictions in which the Company operates. Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. Realization of net deferred tax assets is dependent on future taxable income.

At the end of each interim reporting period, the effective tax rate is aligned with expectations for the full year. This estimate is used to determine the income tax provision on a year-to-date basis and may change in subsequent interim periods.

Income before income taxes and income tax expense (benefit) for the three and six months ended June 30, 2023 and 2022 were as follows:

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands, except percentages)
Income (loss) before income taxes	$	(84,035)	$	10,188	$	(75,031)	$	23,902
Income tax expense (benefit)	$	1,285	$	533	$	1,548	$	917
Effective tax rate		(1.53)%		5.23%		(2.06)%		3.84%

The Company’s tax expense for the three and six months ended June 30, 2023 was $1.3 million and $1.5 million respectively, compared to $0.5 million and $0.9 for the comparable prior periods. For the three and six months ended June 30, 2023, the Company’s income tax expense primarily related to pre-tax income from operations excluding the loss on extinguishment of the 2025 and 2027 Notes. Pursuant to the limitation on losses from extinguishment of convertible notes under Section 249 of the Internal Revenue Code of 1986, as amended (Section 249), the Company recognized a benefit of $0.9 million associated with this loss for the three and six months ended June 30, 2023. Additionally, the income tax expense for the three and six months ended June 30, 2023 was favorably impacted by the tax benefits related to Foreign-Derived Intangible Income and research and development tax credits, as well as discrete income tax benefit for share-based compensation windfall. For the three and six months ended June 30, 2022, the effective tax rate was lower than the U.S. statutory tax rate primarily related to changes in the valuation allowance of deferred tax assets in the U.S.

27

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Note 10 — Segment Reporting and Geographic Information

Veeco operates and measures its results in one operating segment and therefore has one reportable segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make electronic devices.

Veeco serves the following four end-markets:

Semiconductor

The Semiconductor market refers to early process steps in logic and memory applications where silicon wafers are processed. There are many different process steps in forming patterned wafers, such as deposition, etching, masking, and doping, where the microchips are created but remain on the silicon wafer. This market includes mask blank production for extreme ultraviolet (“EUV”) lithography, as well as Advanced Packaging, which refers to a portfolio of wafer-level assembly technologies that enable improved performance of electronic products, such as smartphones, high-end servers, and graphical processors.

Compound Semiconductor

The Compound Semiconductor market includes Photonics, Power Electronics, RF Filters and Amplifiers, and Solar applications. Photonics refers to light source technologies and laser-based solutions for 3D sensing, datacom and telecom applications. This includes micro-LED, laser diodes, edge emitting lasers and vertical cavity surface emitting lasers (“VCSELs”). Power Electronics refers to semiconductor devices such as rectifiers, inverters and converters for the control and conversion of electric power in applications such as fast or wireless charging of consumer electronics and automotive applications. RF power amplifiers and filters (including surface acoustic wave (“SAW”) and bulk acoustic wave (“BAW”) filters) are used in 5G communications infrastructure, smartphones, tablets, and mobile devices. They make use of radio waves for wireless broadcasting and/or communications. Solar refers to power obtained by harnessing the energy of the sun through the use of compound semiconductor devices such as photovoltaics.

Data Storage

Data Storage refers to the Hard Disk Drive (“HDD”) market, for which our systems enable customers to manufacture thin film magnetic heads for hard disk drives as part of large capacity storage applications.

Scientific & Other

Scientific & Other refers to advanced materials research and a range of manufacturing applications including optical coatings (laser mirrors, optical filters, and anti-reflective coatings).

28

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Sales by end-market and geographic region for the three and six months ended June 30, 2023 and 2022 were as follows:

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands)
Sales by end-market
Semiconductor	$	106,275	$	97,521	$	199,382	$	175,141
Compound Semiconductor		24,066		31,122		45,225		68,231
Data Storage		13,945		21,548		35,459		43,143
Scientific & Other		17,355		13,808		35,079		33,910
Total	$	161,641	$	163,999	$	315,145	$	320,425
Sales by geographic region
United States	$	35,739	$	57,940	$	66,750	$	105,410
EMEA(1)		17,511		27,234		40,458		48,660
China		49,986		28,497		110,733		58,878
Rest of APAC		58,320		49,345		97,065		106,267
Rest of World		85		983		139		1,210
Total	$	161,641	$	163,999	$	315,145	$	320,425

(1) EMEA consists of Europe, the Middle East, and Africa

For geographic reporting, sales are attributed to the location in which the customer facility is located.

29

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Statement Regarding Forward Looking Statements

Our discussion below constitutes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this Report, the words “believes,” “anticipates,” “expects,” “estimates,” “targets,” “plans,” “intends,” “will,” and similar expressions related to the future are intended to identify forward-looking statements. All forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from projected results. You should not place undue reliance on any forward-looking statements, which speak only as of the dates they are made.

Executive Summary

We are an innovative manufacturer of semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD, CVD, and single wafer etch & clean technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

Business Update

Macroeconomic challenges across the industry have been well publicized, including supply chain constraints, an inflationary and high-interest rate environment with a potential recession ahead, heightened China-export regulations, uncertainty in the banking industry, and a forecasted decline in the semiconductor and related markets due to softness in consumer, smartphone and PC applications, all of which are contributing to a difficult environment with increased uncertainty.

Longer lead times and parts shortages and allocations have required that we plan further ahead than usual, and we have undertaken efforts to increase our purchase commitments to secure critical components in a timely manner. Our supply chain continues to improve, as evidenced by a decline in lead times and a further improvement to suppliers on time deliveries; however, material lead times remain elevated and continue to be a challenge with respect to our supply chain, limiting our ability to fulfill some of our customers’ demands in a timely manner, as many of our peers have also been experiencing. While we expect lead times to further improve in the second half of the year, we expect supply shortages and related challenges to persist throughout 2023. We continue to monitor our supply chain and work with our suppliers to identify and mitigate potential gaps in an effort to ensure continuity of supply. We also continue to experience increasing labor and material costs, creating gross margin pressures.

We continue to see a slow-down in certain shorter lead time products such as advanced packaging lithography, spare parts, and upgrades, as well as instances where customers have requested order cancellations, delayed shipments, or delayed payments. Consequently, we are monitoring the situation very closely and have been taking early actions to limit the pace at which we increase spending while maintaining our growth trajectory.

Furthermore, the US Department of Commerce, Bureau of Industry and Security (“BIS”), issued China-export regulations on October 7, 2022 which broadened the requirements under which export licenses will be required, with a presumption of denial as to their issuance. In addition, certain China-based companies were added to the BIS Unverified List, and changes have been made to the BIS Entity List, further restricting sales to the named entities. Recent order activity has led to significant backlog in China, some of which may be subject to these regulations. While the export regulation landscape is fluid and evolving, we believe at this time that the substantial majority of this backlog will not be negatively affected by the new regulations.

While we work to overcome these macroeconomic challenges, we continue to serve our customers in the following four end markets: Semiconductor; Compound Semiconductor; Data Storage; and Scientific & Other.

30

Sales in the Semiconductor market during the second quarter grew 9% year-over-year and 14% sequentially, driven by record laser annealing system revenue and shipment of two EUV chambers. We continue to build momentum for our laser annealing solutions in advanced node logic by winning application steps. We recently received orders from several Tier 1 advanced logic customers. While our growth strategy is predominately focused on shipping systems for advanced node logic and memory applications, we have also been receiving orders and shipping systems for trailing node applications in China and other regions. As it relates to the memory market, we recently announced that a Tier 1 memory customer placed several LSA orders for high volume production of DRAM devices following a successful evaluation program. The ongoing adoption of EUV Lithography for advanced node semiconductor manufacturing continues to drive demand for our Ion Beam mask blank systems. Additionally, our lithography systems for Advanced Packaging are aligned with packaging approaches such as fan out wafer level packaging and other advanced packaging applications, while our wet processing systems are used for Photoresist Strip, Solvent Cleans, and flux removal. Overall, our technology and market strategy are well aligned with trends such as artificial intelligence, mobile connectivity and high-performance computing that drive the Semiconductor market. Based on recent order activity and our current backlog in the Semiconductor market, we expect revenue growth in 2023, outpacing wafer fab equipment spending growth, which the prevailing consensus view has forecasted to be down in 2023.

We address the Compound Semiconductor market with a broad portfolio of technologies, including Wet Processing and MOCVD, along with MBE and Ion Beam, all of which have been developed to support emerging applications such as 5G driven RF device/filter manufacturing, GaN power electronics, and photonics applications including edge-emitting lasers, specialty LEDs and micro-LEDs. Sales in the Compound Semiconductor market in Q2 2023 increased as compared to the prior quarter and declined as compared to prior year quarter. In Q2 2023, we shipped several systems for photonics applications. We continue to invest for future growth in the Compound Semiconductor market in areas like power electronics and Micro-LED. Power electronics markets are served by GaN equipment, and also by SiC epitaxy equipment. We are working to penetrate the GaN power market, which is driven by applications such as wireless charging in consumer electronics. In addition to our GaN system offerings, on January 31, 2023 Veeco acquired SiC technology to address the high-growth SiC power epitaxy equipment market, which is primarily driven by adoption of electric vehicles. With this acquisition, Veeco is accelerating its entry into this market, and expects revenue starting in 2024.

Sales in the Data Storage market in Q2 2023 declined as compared to the prior quarter and the prior year quarter. Demand for our Ion Beam products is driven by cloud-based storage. Hard disk drive manufacturers are manufacturing drives with an increasing number of magnetic heads, in addition to introducing advanced technologies requiring increased capital intensity. As reported, the hard disk drive industry experienced contraction in exabyte shipments in 2022 and 2023 with uncertainty as to the timing of a recovery; however, recent analyst and industry forecasts predict nearline hard disk drive exabyte shipments to grow at an approximate 20 to 25% CAGR over the coming years. Despite these current industry challenges, we continue to expect revenue growth in 2023 based on the ship dates of orders in our backlog.

Sales in the Scientific & Other market are largely driven by sales to governments, universities, and research institutions. We address the Scientific & Other market with several technologies, including MBE, ALD, MOCVD, Wet Processing, & IBD/IBE, which support scientific, optical coating and other applications, such as Micro-Electromechanical Systems (MEMS) applications. Sales in this market increased as compared to the quarter in the prior year, while declining as compared to the first quarter of this year. We expect sales in this market to grow in the long run, in line with GDP.

Overall, based on our current visibility supported by our backlog, we continue to expect total 2023 revenue to be in the range of $630 million to $670 million.

31

Results of Operations

For the three months ended June 30, 2023 and 2022

The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for the indicated periods in 2023 and 2022 and the period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, represented by our single operating segment.

	Three Months Ended June 30,						Change
	2023			2022			Period to Period
	(dollars in thousands)
Net sales	$	161,641	100%	$	163,999	100%	$	(2,358)	(1)%
Cost of sales		94,131	58%		99,732	61%		(5,601)	(6)%
Gross profit		67,510	42%		64,267	39%		3,243	5%
Operating expenses, net:
Research and development		27,384	17%		26,016	16%		1,368	5%
Selling, general, and administrative		23,822	15%		22,950	14%		872	4%
Amortization of intangible assets		2,123	1%		2,505	2%		(382)	(15)%
Other operating expense (income), net		493	-		(27)	-		520	*
Total operating expenses, net		53,822	33%		51,444	31%		2,378	5%
Operating income (loss)		13,688	8%		12,823	8%		865	7%
Interest income (expense), net		(632)	(0)%		(2,635)	(2)%		2,003	(76)%
Other income (expense), net		(97,091)	(60)%		—	0%		(97,091)	*
Income (loss) before income taxes		(84,035)	(52)%		10,188	6%		(94,223)	*
Income tax expense (benefit)		1,285	-		533	-		752	141%
Net income (loss)	$	(85,320)	(53)%	$	9,655	6%	$	(94,975)	*

* Not meaningful

Net Sales

The following is an analysis of sales by market and by region:

	Three Months Ended June 30,						Change
	2023			2022			Period to Period
	(dollars in thousands)
Sales by end-market
Semiconductor	$	106,275	65%	$	97,521	60%	$	8,754	9%
Compound Semiconductor		24,066	15%		31,122	19%		(7,056)	(23)%
Data Storage		13,945	9%		21,548	13%		(7,603)	(35)%
Scientific & Other		17,355	11%		13,808	8%		3,547	26%
Total	$	161,641	100%	$	163,999	100%	$	(2,358)	(1)%
Sales by geographic region
United States	$	35,739	22%	$	57,940	35%	$	(22,201)	(38)%
EMEA		17,511	11%		27,234	17%		(9,723)	(36)%
China		49,986	31%		28,497	17%		21,489	75%
Rest of APAC		58,320	36%		49,345	30%		8,975	18%
Rest of World		85	-		983	1%		(898)	*
Total	$	161,641	100%	$	163,999	100%	$	(2,358)	(1)%

* Not meaningful

32

Sales decreased for the three months ended June 30, 2023 against the comparable prior year period in the Data Storage and Compound Semiconductor markets, partially offset by an increase in the Semiconductor market. By geography, sales decreased in the United States and EMEA regions, partially offset by an increase in the China region. Sales in the Rest of APAC region for the three months ended June 30, 2023 included sales in Singapore, Taiwan, and Japan of $22.9 million, $16.1 million, and $12.5 million respectively. Sales in the Rest of APAC region for the three months ended June 30, 2022 included sales in Taiwan and Japan of $28.0 million and $11.0 million, respectively. We expect there will continue to be year-to-year variations in our future sales distribution across markets and geographies. In light of the global nature of our business, we are impacted by conditions in the various countries in which we and our customers operate.

Gross Profit

For the three months ended June 30, 2023, gross profit increased against the comparable prior period due to higher gross margins. Gross margins increased principally due to product mix of sales in the period and favorable spending. We expect our gross margins to fluctuate each period due to product mix and other factors.

Research and Development

The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives. Research and development expenses increased for the three months ended June 30, 2023 against the comparable prior period primarily due to personnel-related expenses as we invest in new research and development and additional applications for our technology in order to be well-positioned to capitalize on emerging global megatrends and support longer term growth in Semiconductor and Compound Semiconductor markets.

Selling, General, and Administrative

Selling, general, and administrative expenses remained flat for the three months ended June 30, 2023 against the comparable prior period. Given the uncertainty regarding the impacts on our business resulting from the general macroeconomic environment, we are focused on the proactive management of expenses.

Amortization Expense

Amortization expense decreased compared to the comparable prior year period primarily due to changes in amortization expense to reflect expected cash flows of certain intangible assets, as well as certain other intangible assets becoming fully amortized in 2022.

Interest Income (Expense)

We recorded net interest expense of $0.6 million for the three months ended June 30, 2023, compared to $2.6 million for the comparable prior year period. The decrease in net interest expense was primarily related to an increase of interest income of approximately $2.4 million due to a more favorable interest rate environment for the three months ended June 30, 2023, against the comparable prior year period.

Other Income (Expense)

On May 19, 2023, in connection with the completion of a private offering of $230.0 million aggregate principal amount of 2.875% convertible senior notes, we repurchased and retired approximately $106.0 million in aggregate principal amount of our outstanding 2025 Notes, with a carrying amount of $105.4 million, for approximately $106.0 million of cash and 0.7 million shares of our common stock for the 2025 Notes. Also, we repurchased and retired approximately $100.0 million in aggregate principal amount of our outstanding 2027 Notes; with a carrying amount of $98.5 million, for approximately $92.8 million of cash and 3.8 million shares of our common stock for the 2027 Notes. We accounted for the partial settlement of the 2025 Notes and 2027 Notes as an extinguishment, and as such, recorded a loss on

33

extinguishment of approximately $16.5 million and $80.6 million, respectively, for the three months ended June 30, 2023.

Income Taxes

At the end of each interim reporting period, we estimate the effective income tax rate expected to be applicable for the full year. This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods.

Our tax expense for the three months ended June 30, 2023 was $1.3 million, compared to $0.5 million for the comparable prior period. For the three months ended June 30, 2023, we incurred income tax expense primarily related to pre-tax income from operations excluding the loss on extinguishment of the 2025 and 2027 Notes. Pursuant to Section 249 limitation on losses from extinguishment of convertible notes, we recognized a benefit of $0.9 million associated with this loss for the three months ended June 30, 2023. Additionally, the $1.3 million of income tax expense for the three months ended June 30, 2023 was favorably impacted by the tax benefits related to Foreign-Derived Intangible Income and research and development tax credits. For the three months ended June 30, 2022, the effective tax rate was lower than the U.S. statutory tax rate primarily related to changes in the valuation allowance of deferred tax assets in the U.S.

For the six months ended June 30, 2023 and 2022

The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for the indicated periods in 2023 and 2022 and the period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, represented by our single operating segment.

	Six Months Ended June 30,						Change
	2023			2022			Period to Period
	(dollars in thousands)
Net sales	$	315,145	100%	$	320,425	100%	$	(5,280)	(2)%
Cost of sales		185,618	59%		190,146	59%		(4,528)	(2)%
Gross profit		129,527	41%		130,279	41%		(752)	(1)%
Operating expenses, net:
Research and development		54,945	17%		50,133	16%		4,812	10%
Selling, general, and administrative		46,449	15%		45,844	14%		605	1%
Amortization of intangible assets		4,235	1%		5,009	2%		(774)	(15)%
Other operating expense (income), net		404	-		(47)	-		451	*
Total operating expenses, net		106,033	34%		100,939	32%		5,094	5%
Operating income (loss)		23,494	7%		29,340	9%		(5,846)	(20)%
Interest income (expense), net		(1,434)	(0)%		(5,438)	(2)%		4,004	(74)%
Other income (expense), net		(97,091)	(31)%		—	0%		(97,091)	*
Income (loss) before income taxes		(75,031)	(24)%		23,902	7%		(98,933)	*
Income tax expense (benefit)		1,548	-		917	-		631	69%
Net income (loss)	$	(76,579)	(24)%	$	22,985	7%	$	(99,564)	*

* Not meaningful

34

Net Sales

The following is an analysis of sales by market and by region:

	Six Months Ended June 30,						Change
	2023			2022			Period to Period
	(dollars in thousands)
Sales by end-market
Semiconductor	$	199,382	64%	$	175,141	55%	$	24,241	14%
Compound Semiconductor		45,225	14%		68,231	21%		(23,006)	(34)%
Data Storage		35,459	11%		43,143	13%		(7,684)	(18)%
Scientific & Other		35,079	11%		33,910	11%		1,169	3%
Total	$	315,145	100%	$	320,425	100%	$	(5,280)	(2)%
Sales by geographic region
United States	$	66,750	21%	$	105,410	33%	$	(38,660)	(37)%
EMEA		40,458	13%		48,660	15%		(8,202)	(17)%
China		110,733	35%		58,878	19%		51,855	88%
Rest of APAC		97,065	31%		106,267	33%		(9,202)	(9)%
Rest of World		139	-		1,210	-		(1,071)	*
Total	$	315,145	100%	$	320,425	100%	$	(5,280)	(2)%

* Not meaningful

Sales decreased for the six months ended June 30, 2023 against the comparable prior year period in the Compound Semiconductor and Data Storage markets, partially offset by an increase in the Semiconductor market. By geography, sales decreased in the United States, Rest of APAC, and EMEA regions, partially offset by an increase in the China region. Sales in the Rest of APAC region for the six months ended June 30, 2023 included sales in Taiwan, Singapore, Japan, and Thailand of $34.1 million, $25.8 million, $16.9 million, and $10.4 million respectively. Sales in the Rest of APAC region for the six months ended June 30, 2022 included sales in Taiwan, Singapore and Japan of $45.2 million and $25.9 million, and $15.2 million, respectively. We expect there will continue to be year-to-year variations in our future sales distribution across markets and geographies. In light of the global nature of our business, we are impacted by conditions in the various countries in which we and our customers operate.

Gross Profit

For the six months ended June 30, 2023, gross profit remained flat against the comparable prior period. Gross margins also remained flat, as favorable spending was offset by a decrease in sales volume and product mix of sales in the period. We expect our gross margins to fluctuate each period due to product mix and other factors.

Research and Development

The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives. Research and development expenses increased for the six months ended June 30, 2023 against the comparable prior period primarily due to personnel-related expenses as we invest in new research and development and additional applications for our technology in order to be well-positioned to capitalize on emerging global megatrends and support longer term growth in Semiconductor and Compound Semiconductor markets.

Selling, General, and Administrative

Selling, general, and administrative expenses remained flat for the six months ended June 30, 2023 against the comparable prior period. Given the uncertainty regarding the impacts on our business resulting from the general macroeconomic environment, we are focused on the proactive management of expenses.

35

Amortization Expense

Amortization expense decreased compared to the comparable prior year period primarily due to changes in amortization expense to reflect expected cash flows of certain intangible assets, as well as certain other intangible assets becoming fully amortized in 2022.

Interest Income (Expense)

We recorded net interest expense of $1.4 million for the six months ended June 30, 2023, compared to $5.4 million for the comparable prior year period. The decrease in net interest expense was primarily related to an increase of interest income of approximately $4.5 million due to a more favorable interest rate environment for the six months ended June 30, 2023, against the comparable prior year period.

Other Income (Expense)

On May 19, 2023, in connection with the completion of a private offering of $230.0 million aggregate principal amount of 2.875% convertible senior notes, we repurchased and retired approximately $106.0 million in aggregate principal amount of our outstanding 2025 Notes; with a carrying amount of $105.4 million, for approximately $106.0 million of cash and 0.7 million shares of our common stock for the 2025 Notes. Also, we repurchased and retired approximately $100.0 million in aggregate principal amount of our outstanding 2027 Notes; with a carrying amount of $98.5 million, for approximately $92.8 million of cash and 3.8 million shares of our common stock for the 2027 Notes. We accounted for the partial settlement of the 2025 Notes and 2027 Notes as an extinguishment, and as such, recorded a loss on extinguishment of approximately $16.5 million and $80.6 million, respectively, for the six months ended June 30, 2023.

Income Taxes

At the end of each interim reporting period, we estimate the effective income tax rate expected to be applicable for the full year. This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods.

Our tax expense for the six months ended June 30, 2023 was $1.5 million, compared to $0.9 million for the comparable prior period. For the six months ended June 30, 2023, we incurred income tax expense primarily related to pre-tax income from operations excluding the loss on extinguishment of the 2025 and 2027 Notes. Pursuant to Section 249 limitation on losses from extinguishment of convertible notes, we recognized a benefit of $0.9 million with this loss for the six months ended June 30, 2023. Additionally, the $1.5 million of income tax expense for the six months ended June 30, 2023 was favorably impacted by the tax benefits related to Foreign-Derived Intangible Income and research and development tax credits, as well as a discrete income tax benefit for share-based compensation windfall. For the six months ended June 30, 2022, the effective tax rate was lower than the U.S. statutory tax rate primarily related to changes in the valuation allowance of deferred tax assets in the U.S.

Liquidity and Capital Resources

Our cash and cash equivalents, restricted cash, and short-term investments are as follows:

	June 30,		December 31,
	2023		2022
	(in thousands)
Cash and cash equivalents	$	180,524	$	154,925
Restricted cash		437		547
Short-term investments		105,875		147,488
Total	$	286,836	$	302,960

At June 30, 2023 and December 31, 2022, cash and cash equivalents of $38.8 million and $28.4 million, respectively, were held outside the United States. As of June 30, 2023, we had $19.8 million of accumulated undistributed earnings

36

generated by our non-U.S. subsidiaries for which the U.S. tax has previously been provided. Approximately $8.5 million of undistributed earnings will be subject to foreign withholding taxes if distributed back to the United States and we accrued $0.9 million for foreign withholding taxes for the undistributed earnings.

We believe that our projected cash flow from operations, combined with our cash and short-term investments, will be sufficient to meet our projected working capital requirements, contractual obligations, and other cash flow needs for the next twelve months, including scheduled interest payments on our convertible senior notes, purchase commitments, and payments in respect of operating leases.

A summary of the cash flow activity for the six months ended June 30, 2023 and 2022 is as follows:

Cash Flows from Operating Activities

	Six Months Ended June 30,
	2023		2022
	(in thousands)
Net income (loss)	$	(76,579)	$	22,985
Non-cash items:
Depreciation and amortization		12,435		12,749
Non-cash interest expense		514		477
Deferred income taxes		778		(18)
Share-based compensation expense		14,959		10,759
Loss on extinguishment of debt		97,091		—
Provision for bad debts		490		—
Changes in operating assets and liabilities		(24,553)		(18,783)
Net cash provided by (used in) operating activities	$	25,135	$	28,169

Net cash provided by operating activities was $25.1 million for the six months ended June 30, 2023 and was due to net loss of $76.6 million and adjustments for non-cash items of $126.3 million, partially offset by a decrease in cash flow from changes in operating assets and liabilities of $24.6 million. The changes in operating assets and liabilities were largely attributable to increases in inventories, accounts receivables, and contract assets; partially offset by increases in customer deposits, accounts payable, and accrued expenses.

Cash Flows from Investing Activities

	Six Months Ended June 30,
	2023		2022
	(in thousands)
Acquisitions of businesses, net of cash acquired	$	(30,373)	$	—
Capital expenditures		(10,836)		(15,420)
Changes in investments, net		43,575		(10,541)
Net cash provided by (used in) investing activities	$	2,366	$	(25,961)

The cash provided by investing activities during the six months ended June 30, 2023 was primarily attributable to net investment activity, partially offset by the net cash used in the acquisition of Epiluvac, and capital expenditures. The cash used in investing activities during the six months ended June 30, 2022 was mainly due to a high level of capital expenditures during 2022 associated with the continued build-out of our newly leased facility in San Jose, California, which is substantially complete at this time.

37

Cash Flows from Financing Activities

	Six Months Ended June 30,
	2023		2022
	(in thousands)
Proceeds from issuance of 2029 Notes, net of issuance costs	$	223,202	$	—
Extinguishment of Convertible Notes		(218,991)		—
Settlement of equity awards, net of withholding taxes		(6,182)	$	(4,986)
Net cash provided by (used in) financing activities	$	(1,971)	$	(4,986)

The cash used in financing activities for the six months ended June 30, 2023 was related to the partial repurchase of the 2025 Notes and 2027 Notes, repayment of the 2023 Notes, as well as cash used to settle taxes related to employee equity programs, partially offset by proceeds from issuance of 2029 Notes.

Convertible Senior Notes

We have $26.5 million outstanding principal balance of 3.50% convertible senior notes that bear interest at a rate of 3.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, and mature on January 15, 2025, unless earlier purchased by the Company, redeemed, or converted. In addition, we have $25.0 million outstanding principal balance of 3.75% convertible senior notes that bear interest at a rate of 3.75% per year, payable semiannually in arrears on June 1 and December 1 of each year, and mature on June 1, 2027, unless earlier purchased by the Company, redeemed, or converted. The 2027 Notes are currently convertible by shareholders until June 30, 2023. In addition, we have $230.0 million outstanding principal balance of 2.875% convertible senior notes that bear interest at a rate of 2.875% per year, payable semiannually in arrears on June 1 and December 1 of each year, and mature on June 1, 2029, unless earlier purchased by the Company, redeemed, or converted.

We believe that we have sufficient capital resources and cash flows from operations to support scheduled interest payments on these debts. In addition, we have access to a $150.0 million revolving credit facility (including an ability to request an additional $75.0 million, for a total commitment of no more than $225.0 million) to provide for our working capital needs and reimburse drawings under letters of credit and for other general corporate purposes. The Company has no immediate plans to draw down on the facility, which expires in December of 2026. Interest under the facility is variable based on the Company’s secured net leverage ratio and is expected to bear interest based on SOFR plus a range of 150 to 225 basis points, if drawn. There is a yearly commitment fee of 25 to 35 basis points, based on the Company’s secured net leverage ratio, charged on the unused portion of the Facility.

Contractual Obligations and Commitments

We have commitments under certain contractual arrangements to make future payments for goods and services. These contractual arrangements secure the rights to various assets and services to be used in the future in the normal course of business. We expect to fund these contractual arrangements with cash generated from operations in the normal course of business.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Risk

Our exposure to market rate risk for changes in interest rates primarily relates to our investment portfolio. We centrally manage our investment portfolios considering investment opportunities and risks, tax consequences, and overall financing strategies. Our investment portfolio includes fixed-income securities with a fair value of approximately $105.9 million at June 30, 2023. These securities are subject to interest rate risk and, based on our investment portfolio at June 30, 2023, a 100 basis point increase in interest rates would result in a decrease in the fair value of the portfolio of $0.6 million. While an increase in interest rates may reduce the fair value of the investment portfolio, we will not realize the losses in the Consolidated Statements of Operations unless the individual fixed-income securities are sold prior to recovery or the loss is determined to be other-than-temporary.

38

Currency Exchange Risk

We conduct business on a worldwide basis and, as such, a portion of our revenues, earnings, and net investments in foreign affiliates is exposed to changes in currency exchange rates. The economic impact of currency exchange rate movements is complex because such changes are often linked to variability in real growth, inflation, interest rates, governmental actions, and other factors. These changes, if material, could cause us to adjust our financing and operating strategies. Consequently, isolating the effect of changes in currency does not incorporate these other important economic factors.

Changes in currency exchange rates could affect our foreign currency denominated monetary assets and liabilities and forecasted cash flows. We may enter into monthly forward derivative contracts from time to time with the intent of mitigating a portion of this risk. We only use derivative financial instruments in the context of hedging and not for speculative purposes and have not historically designated our foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts are recorded as “Other, net” in our Consolidated Statements of Operations. We execute derivative transactions with highly rated financial institutions to mitigate counterparty risk.

Our net sales to customers located outside of the United States represented approximately 78% and 79% of our total net sales for the three and six months ended June 30, 2023, respectively, 65% and 67% for the comparable 2022 periods. We expect that net sales to customers outside the United States will continue to represent a large percentage of our total net sales. Our sales denominated in currencies other than the U.S. dollar represented approximately 3% of total net sales for both the three and six months ended June 30, 2023 and 2022.

A 10% change in foreign exchange rates would have an immaterial impact on the consolidated results of operations since most of our sales outside the United States are denominated in U.S. dollars.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our principal executive and financial officers have evaluated and concluded that our disclosure controls and procedures are effective as of June 30, 2023. The disclosure controls and procedures are designed to ensure that the information required to be disclosed in this report filed under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to our principal executive and financial officers as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

On January 31, 2023, we completed the acquisition of Epiluvac AB and are integrating the acquired business into our overall internal control over financial reporting process. Management is in the process of assessing the internal control over financial reporting and is implementing or revising internal controls where necessary. See Note 3 to the Consolidated Financial Statements – Business Combinations, for further details. There were no other changes in internal control for the quarter ended June 30, 2023 that have materially affected or are reasonably likely to materially affect internal control over financial reporting.

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

The Company is involved in various legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

39

Item 1A. Risk Factors

Information regarding risk factors appears in the Safe Harbor Statement at the beginning of this quarterly report on Form 10-Q and in Part I — Item 1A of our 2022 Form 10-K. There have been no material changes from the risk factors previously disclosed, except as follows:

Our current debt facilities, including our 3.50% Convertible Senior notes due 2025 (the “2025 Notes”), our 3.75% Convertible Notes due 2027 (the “2027 Notes”), and our 2.875% Convertible Notes due 2029 (the “2029 Notes”) (the 2025 Notes, 2027 Notes, and 2029 Notes together the “Notes”), and our revolving credit facility (the “Credit facility”), contains certain restrictions, covenants and repurchase provisions that may limit our ability to raise the funds necessary to meet our working capital needs, which may include the cash conversion of the Notes or repurchase of the Notes for Cash upon a fundamental change.

As of June 30, 2023, we had $26.5 million in principal amounts outstanding in 2025 Notes, $25.0 million in principal amounts outstanding in 2027 Notes, and $230.0 million in principal amounts outstanding in 2029 Notes. In addition, as of June 30, 2023 we had an undrawn senior secured revolving credit facility in an aggregate principal amount of $150.0 million, including a $15.0 million letter of credit sublimit.

These debt facilities contain certain covenant and other restrictions that may limit our ability to, among other things, incur additional debt or create liens, sell certain assets, and merge or consolidate with third parties, which may, in turn, preclude us from responding to changes in business and economic conditions, engaging in transactions that might otherwise be beneficial to us, or obtaining additional financing. Our ability to comply with some of these covenants is dependent on our future performance, which will be subject to many factors, some of which are beyond our control such as prevailing economic conditions. In addition, our failure to comply with these covenants could result in a default under the Notes or Credit Facility, which could accelerate the debt. If any of our debt is accelerated, we may not have sufficient funds available to repay such debt, which could materially and negatively affect our financial condition and results of operation.

In addition, our ability to repurchase or to pay cash upon conversion of the Notes, or maturity of the Credit Facility, may be limited by law, by regulatory authority or by agreements governing our indebtedness that exist at the time of repurchase, conversion, or maturity. Our failure to settle the debt as required would constitute a default under the applicable debt facility and could also lead to a default under the other debt facilities. If the payment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness.

Finally, holders of the Notes will have the right to require us to repurchase all or any portion of their Notes upon the occurrence of a fundamental change before the maturity date. Additionally, in the event the conditional conversion features of the 2025 Notes, 2027 Notes, and 2029 Notes are triggered (as is currently the case for the 2027 Notes through September 30, 2023), holders of Notes will be entitled to convert the Notes at any time during specified periods at their option. If one or more holders elect to convert the Notes, or if a fundamental change occurs before maturity, unless we elect to deliver solely shares of our common stock to settle such conversion (other than paying cash in lieu of delivering any fractional share), we will be required to make cash payments in respect of the Notes being converted, which could adversely impact our liquidity. Additionally, we may not have enough available cash or be able to obtain financing at the time we are required to make repurchases of the Notes surrendered therefor or pay cash with respect to the Notes being converted. In addition, even if holders do not elect to convert the Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Notes as a current rather than long-term liability, which could result in a material reduction of our net working capital.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

40

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

None.

41

Item 6. Exhibits

Unless otherwise indicated, each of the following exhibits has been filed with the Securities and Exchange Commission by Veeco under File No. 0-16244.

Exhibit		Incorporated by Reference			Filed or Furnished
Number	Exhibit Description	Form	Exhibit	Filing Date	Herewith
4.1	Indenture, dated as of May 19, 2023, between Veeco Instruments Inc. and U.S. Bank Trust Company, National Association, as trustee.	8-K	4.1	5/22/2023
4.2	Form of 2.875% Convertible Senior Notes due 2029 (included in Exhibit 4.1).	8-K	4.2	5/22/2023
10.1	First Amendment to Loan and Security Agreement, dated as of May 19, 2023, by and among Veeco Instruments Inc., as borrower, the guarantors party thereto, the lenders from time to time party thereto and HSBC Bank USA, National Association, as administrative agent, collateral agent, joint lead arranger, and joint bookrunner, Barclays bank PLC, as joint lead arranger and joint bookrunner, and Santander Bank, N.A.	8-K	10.1	5/22/2023
31.1	Certification of Chief Executive Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of the Securities and Exchange Act of 1934.				*
31.2	Certification of Chief Financial Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of the Securities and Exchange Act of 1934.				*
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.				*
32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.				*
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.				*
101.XSD	XBRL Schema.				**
101.PRE	XBRL Presentation.				**
101.CAL	XBRL Calculation.				**
101.DEF	XBRL Definition.				**
101.LAB	XBRL Label.				**
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).				**

*     Filed herewith

**   Filed herewith electronically

42

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on August 7, 2023.

Veeco Instruments Inc.
By:	/s/ WILLIAM J. MILLER, Ph.D.
	William J. Miller, Ph.D.
	Chief Executive Officer
By:	/s/ JOHN P. KIERNAN
	John P. Kiernan
	Senior Vice President and Chief Financial Officer

43

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULE 13a — 14(a) or RULE 15d — 14(a)

OF THE SECURITIES EXCHANGE ACT OF 1934

I, William J. Miller, Ph.D., certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended June 30, 2023 of Veeco Instruments Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ WILLIAM J. MILLER, Ph.D.
	William J. Miller, Ph.D.
	Chief Executive Officer
	Veeco Instruments Inc.
	August 7, 2023

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULE 13a — 14(a) or RULE 15d — 14(a)

OF THE SECURITIES EXCHANGE ACT OF 1934

I,  John P. Kiernan, certify that:

1.    I have reviewed this quarterly report on Form 10-Q for the period ended June 30, 2023 of Veeco Instruments Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)  designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)  evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)  disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ JOHN P. KIERNAN
	John P. Kiernan
	Senior Vice President and Chief Financial Officer
	Veeco Instruments Inc.
	August 7, 2023

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Veeco Instruments Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William J. Miller, Ph.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ WILLIAM J. MILLER Ph.D.
	William J. Miller, Ph.D.
	Chief Executive Officer
	Veeco Instruments Inc.
	August 7, 2023

A signed original of this written statement required by Section 906 has been provided to Veeco Instruments Inc. and will be retained by Veeco Instruments Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Veeco Instruments Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John P. Kiernan, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ JOHN P. KIERNAN
	John P. Kiernan
	Senior Vice President and Chief Financial Officer
	Veeco Instruments Inc.
	August 7, 2023

A signed original of this written statement required by Section 906 has been provided to Veeco Instruments Inc. and will be retained by Veeco Instruments Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2023	Aug. 01, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	0-16244
Entity Registrant Name	VEECO INSTRUMENTS INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	11-2989601
Entity Address, Address Line One	Terminal Drive
Entity Address, City or Town	Plainview
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11803
City Area Code	516
Local Phone Number	677-0200
Title of 12(b) Security	Common Stock
Trading Symbol	VECO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		56,345,525
Entity Central Index Key	0000103145
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 180,524	$ 154,925
Restricted cash	437	547
Short-term investments	105,875	147,488
Accounts receivable, net	130,140	124,221
Contract assets	20,490	16,507
Inventories	244,470	206,908
Prepaid expenses and other current assets	27,218	18,305
Total current assets	709,154	668,901
Property, plant, and equipment, net	111,993	107,281
Operating lease right-of-use assets	25,611	26,467
Intangible assets, net	48,192	23,887
Goodwill	214,964	181,943
Deferred income taxes	115,314	116,349
Other assets	3,219	3,355
Total assets	1,228,447	1,128,183
Current liabilities:
Accounts payable	63,212	52,049
Accrued expenses and other current liabilities	61,823	56,031
Customer deposits and deferred revenue	156,700	127,223
Income taxes payable	563	2,432
Current portion of long-term debt		20,169
Total current liabilities	282,298	257,904
Deferred income taxes	6,878	1,285
Long-term debt	274,335	254,491
Long-term operating lease liabilities	32,838	33,581
Other liabilities	19,498	3,098
Total liabilities	615,847	550,359
Stockholders' equity:
Preferred stock, $0.01 par value; 500,000 shares authorized; no shares issued and outstanding.
Common stock, $0.01 par value; 120,000,000 shares authorized; 56,337,933 shares issued and outstanding at June 30, 2023 and 51,660,409 shares issued and outstanding at December 31, 2022	564	517
Additional paid-in capital	1,189,051	1,078,180
Accumulated deficit	(578,380)	(501,801)
Accumulated other comprehensive income	1,365	928
Total stockholders' equity	612,600	577,824
Total liabilities and stockholders' equity	$ 1,228,447	$ 1,128,183

XML

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Consolidated Balance Sheets
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized shares	120,000,000	120,000,000
Common stock, shares issued	56,337,933	51,660,409
Common stock, shares outstanding	56,337,933	51,660,409

XML

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Consolidated Statements of Operations
Net sales	$ 161,641	$ 163,999	$ 315,145	$ 320,425
Cost of sales	94,131	99,732	185,618	190,146
Gross profit	67,510	64,267	129,527	130,279
Operating expenses, net:
Research and development	27,384	26,016	54,945	50,133
Selling, general, and administrative	23,822	22,950	46,449	45,844
Amortization of intangible assets	2,123	2,505	4,235	5,009
Other operating expense (income), net	493	(27)	404	(47)
Total operating expenses, net	53,822	51,444	106,033	100,939
Operating income	13,688	12,823	23,494	29,340
Interest income	2,420	213	4,494	302
Interest expense	(3,052)	(2,848)	(5,928)	(5,740)
Other income (expense), net	(97,091)		(97,091)
Income (loss) before income taxes	(84,035)	10,188	(75,031)	23,902
Income tax expense (benefit)	1,285	533	1,548	917
Net income (loss)	$ (85,320)	$ 9,655	$ (76,579)	$ 22,985
Income (loss) per common share:
Basic (in dollars per share)	$ (1.61)	$ 0.19	$ (1.48)	$ 0.46
Diluted (in dollars per share)	$ (1.61)	$ 0.18	$ (1.48)	$ 0.43
Weighted average number of shares:
Basic (in shares)	52,861	49,697	51,764	49,702
Diluted (in shares)	52,861	59,455	51,764	59,521

XML

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Consolidated Statements of Comprehensive Income
Net Income (Loss)	$ (85,320)	$ 9,655	$ (76,579)	$ 22,985
Other comprehensive income (loss), net of tax:
Unrealized gain (loss) on available-for-sale securities		(224)	470	(1,043)
Change in currency translation adjustments	(39)	(48)	(33)	(51)
Total other comprehensive income (loss), net of tax	(39)	(272)	437	(1,094)
Total comprehensive income (loss)	$ (85,359)	$ 9,383	$ (76,142)	$ 21,891

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash Flows from Operating Activities
Net income (loss)	$ (76,579)	$ 22,985
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	12,435	12,749
Non-cash interest expense	514	477
Deferred income taxes	778	(18)
Share-based compensation expense	14,959	10,759
Loss on extinguishment of debt	97,091
Provision for bad debts	490
Changes in operating assets and liabilities:
Accounts receivable and contract assets	(10,145)	(16,346)
Inventories	(44,540)	(5,873)
Prepaid expenses and other current assets	(5,633)	8,231
Accounts payable and accrued expenses	9,099	(17,613)
Customer deposits and deferred revenue	29,048	11,424
Income taxes receivable and payable, net	(1,869)	(263)
Other, net	(513)	1,657
Net cash provided by (used in) operating activities	25,135	28,169
Cash Flows from Investing Activities
Capital expenditures	(10,836)	(15,420)
Acquisition of businesses, net of cash acquired	(30,373)
Proceeds from the sale of investments	112,895	23,335
Payments for purchases of investments	(69,320)	(33,876)
Net cash provided by (used in) investing activities	2,366	(25,961)
Cash Flows from Financing Activities
Proceeds from issuance of 2029 Notes, net of issuance costs	223,202
Extinguishment of Convertible Notes	(218,991)
Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan	2,619	2,129
Restricted stock tax withholdings	(8,801)	(7,115)
Net cash provided by (used in) financing activities	(1,971)	(4,986)
Effect of exchange rate changes on cash and cash equivalents	(41)	(51)
Net increase (decrease) in cash, cash equivalents, and restricted cash	25,489	(2,829)
Cash, cash equivalents, and restricted cash - beginning of period	155,472	120,472
Cash, cash equivalents, and restricted cash - end of period	180,961	117,643
Supplemental Disclosure of Cash Flow Information
Interest paid	6,628	5,037
Income taxes paid	2,983	1,083
Non-cash activities
Capital expenditures included in accounts payable and accrued expenses	3,938	6,464
Net transfer of inventory to property, plant and equipment	4,328	237
Right-of-use assets obtained in exchange for lease obligations	$ 630	$ 258

XML

Basis of Presentation

6 Months Ended

Jun. 30, 2023

Basis of Presentation

Basis of Presentation

Note 1 — Basis of Presentation

The accompanying unaudited Consolidated Financial Statements of Veeco have been prepared in accordance with U.S. GAAP as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 270 for interim financial information and with the instructions to Rule 10-01 of Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements as the interim information is an update of the information that was presented in Veeco’s most recent annual financial statements. For further information, refer to Veeco’s Consolidated Financial Statements and Notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2022 (“2022 Form 10-K”). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal, recurring nature.

Veeco reports interim quarters on a 13-week basis ending on the last Sunday of each quarter. The fourth quarter always ends on the last day of the calendar year, December 31. The 2023 interim quarters end on April 2, July 2, and October 1, and the 2022 interim quarters ended on April 3, July 3, and October 2. These interim quarters are reported as March 31, June 30, and September 30 in Veeco’s interim consolidated financial statements.

The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, actual results may differ from these estimates.

Revenue Recognition

Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, the Company estimates the amount of variable consideration and determines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another.

When there are separate units of accounting, the Company allocates revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items that are not sold separately, the Company estimates stand-alone selling prices generally using an expected cost plus margin approach.

Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in the Company’s facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed

internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. The Company recognizes such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

In certain cases the Company’s contracts with customers contain a billing retention, which is billed by the Company and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets.

The Company recognizes revenue related to maintenance and service contracts over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or generally expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred since the expected amortization period is one year or less.

The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in cost of sales when the Company recognizes revenue for the related goods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue.

Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for the Company’s products may require a write down of inventory, which would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition.

XML

Income Per Common Share

6 Months Ended

Jun. 30, 2023

Income Per Common Share

Income Per Common Share

Note 2 — Income Per Common Share

Basic income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted income per share is calculated by dividing net income available to common shareholders by the weighted average number of shares used to calculate basic income per share plus the weighted average number of common share equivalents outstanding during the period. The dilutive effect of outstanding options to purchase common stock and share-based awards is considered in diluted income per share by application of the treasury stock method. The dilutive effect of performance share units is included in diluted income per common share if the performance targets have been achieved, or would have been achieved if the reporting date was the end of the contingency period. Finally, the Company includes the dilutive effect of shares issuable upon conversion of its Notes in the calculation of diluted income per share using the if-converted method. The Company has the option for the 2025 and 2027 Notes to settle the conversion value in any combination of cash or shares, and as such, the maximum number of shares issuable are included in the dilutive share count if the effect would be dilutive. The Company must settle the principal amount of the 2029 Notes in cash, and has the option to settle any excess of the conversion value over the principal amount in any combination of cash or shares. As such, the Company only includes the excess shares that may be issuable above the principal amount of the 2029 Notes in the dilutive share count, if the effect would be dilutive.

The computations of basic and diluted income per share for the three and six months ended June 30, 2023 and 2022 are as follows:

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands, except per share amounts)
Numerator:
Net income (loss)	$	(85,320)	$	9,655	$	(76,579)	$	22,985
Interest expense associated with convertible notes		—		1,273		—		2,546
Net income (loss) available to common shareholders	$	(85,320)	$	10,928	$	(76,579)	$	25,531
Denominator:
Basic weighted average shares outstanding		52,861		49,697		51,764		49,702
Effect of potentially dilutive share-based awards		—		816		—		877
Dilutive effect of convertible notes		—		8,942		—		8,942
Diluted weighted average shares outstanding		52,861		59,455		51,764		59,521
Net income per common share:
Basic	$	(1.61)	$	0.19	$	(1.48)	$	0.46
Diluted	$	(1.61)	$	0.18	$	(1.48)	$	0.43
Common share equivalents excluded from the diluted weighted average shares outstanding since the Company incurred a net loss and their effect would be antidilutive		838		N/A		674		N/A
Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive		743		987		763		645
Potential shares to be issued for settlement of the convertible notes excluded from the diluted calculation as their effect would be antidilutive		8,868		6,025		11,722		6,025

XML

Business Combination

6 Months Ended

Jun. 30, 2023

Business Combination

Business Combination

Note 3 — Business Combination

Epiluvac

On January 31, 2023, the Company acquired Epiluvac AB, a privately held manufacturer of chemical vapor deposition (CVD) epitaxy systems that enable silicon carbide (SiC) applications in the electric vehicle market. This acquisition is expected to accelerate penetration into the emerging, high-growth SiC equipment market. The results of Epiluvac’s operations have been included in the consolidated financial statements since the date of acquisition.

The acquisition date fair value of the consideration totaled $56.4 million, net of cash acquired, which consisted of the following:

	Acquisition Date
	(January 31, 2023)
	(in thousands)
Cash paid, net of cash acquired	$	30,373
Contingent consideration		26,055
Acquisition date fair value	$	56,428

The purchase agreement included performance milestones that, if achieved, could trigger additional payments to the original selling shareholders. The aggregate fair value of the contingent consideration arrangement at the acquisition date was $26.1 million. During the three months ended June 30, 2023, the Company recognized approximately $0.3 million of additional contingent consideration, for total contingent consideration of $26.4 million as of June 30, 2023, of which $9.8 million was included in “Accrued expenses and other current liabilities” and $16.6 million was included within “Other liabilities” on the Consolidated Balance Sheet as of June 30, 2023. The contingent arrangements include payments up to $15.0 million based on the timely completion of certain defined milestones tied to strategic targets, and up to $20.0 million based on the percentage of orders received during the defined Earn-out period. The Earn-out period is four years after the closing date of the acquisition, or earlier if certain conditions are met.

The Company estimated the fair value of the contingent consideration by assigning probabilities and discount factors to each of the various defined performance milestones, while using a Monte-Carlo simulation model to determine the most likely outcome for payments to be based on value of orders received. These fair value measurements are based on significant inputs not observable in the market and thus represent a Level 3 measurement as defined in ASC 820. The discount rate used was 5.54% for the strategic target and order value related contingent payments. The rate was determined based on the nature of the milestone, the risks and uncertainties involved and the time period until the milestone was measured. The determination of the various probabilities and discount factors is highly subjective, requires significant judgment and is influenced by a number of factors, including the adoption of SiC technology. While the use of SiC is expected to grow in the near future, it is difficult to predict the rate at which SiC will be adopted by the market and thus would impact the sales of our equipment.

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date:

	Acquisition Date
	(January 31, 2023)
	(in thousands)
Accounts receivable	$	247
Inventories		391
Prepaid expense and other current assets		381
Property, plant, and equipment		736
Intangible assets		28,540
Total identifiable assets acquired		30,295
Accounts payable and accrued expenses		656
Customer deposits and deferred revenue		429
Deferred income taxes		5,723
Other liabilities		80
Total liabilities assumed		6,888
Net identifiable assets acquired		23,407
Goodwill		33,021
Net assets acquired	$	56,428

The gross contractual value of the acquired accounts receivable is the amount expected to be collected by the Company, and therefore is also considered its fair value. Goodwill generated from the acquisition is primarily attributed to expected synergies from future growth and strategic advantages provided through the expansion of product offerings as well as assembled workforce and is not expected to be deductible for income tax purposes.

The classes of intangible assets acquired, and the estimated useful life of each class is presented in the table below:

	Acquisition Date
	(January 31, 2023)
	Amount		Useful life
	(in thousands)
Technology	$	28,020	15	years
Customer relationships		460	5	years
Backlog		60	1.5	years
Intangible assets acquired	$	28,540

The Company determined the estimated fair value of the identifiable intangible assets based on various factors including cost, discounted cash flow, income method, loss-of-revenue/income method, and relief-from-royalty method in determining the purchase price allocation.

For the three and six months ended June 30, 2023, the Company incurred approximately $0.2 million and $0.9 million, respectively, of acquisition related costs, included within “Selling, general, and administrative” in the Consolidated Statement of Operations. Epiluvac’s results of operations were immaterial to the Company’s Consolidated Statement of Operations for the three and six months ended June 30, 2023. Additionally, the pro forma Consolidated Statement of Operations as if Epiluvac had been acquired as of January 1, 2022 would not be materially different from the Company’s actual Consolidated Statement of Operations for the three and six months ended June 30, 2023 or 2022.

XML

Assets

6 Months Ended

Jun. 30, 2023

Assets

Assets

Note 4 — Assets

Investments

Short-term investments are generally classified as available-for-sale and reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income” in the Consolidated Balance Sheets. These securities may include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other operating expense (income), net” in the Consolidated Statements of Operations.

Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. Veeco classifies certain assets based on the following fair value hierarchy:

Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Veeco has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions or estimation methodologies could have a significant effect on the estimated fair value amounts.

The following table presents the portion of Veeco’s assets that were measured at fair value on a recurring basis at June 30, 2023 and December 31, 2022:

	Level 1		Level 2		Level 3		Total
	(in thousands)
June 30, 2023
Cash equivalents
Certificate of deposits and time deposits	$	57,432	$	—	$	—	$	57,432
Commercial paper		—		11,475		—		11,475
Money market cash		50,846		—		—		50,846
Total	$	108,278	$	11,475	$	—	$	119,753
Short-term investments
U.S. treasuries	$	12,041	$	—	$	—	$	12,041
Government agency securities		—		60,054		—		60,054
Corporate debt		—		13,020		—		13,020
Commercial paper		—		20,760		—		20,760
Total	$	12,041	$	93,834	$	—	$	105,875
December 31, 2022
Cash equivalents
Certificate of deposits and time deposits	$	61,135	$	—	$	—	$	61,135
Money market cash		405		—		—		405
Total	$	61,540	$	—	$	—	$	61,540
Short-term investments
U.S. treasuries	$	62,849	$	—	$	—	$	62,849
Government agency securities		—		27,366		—		27,366
Corporate debt		—		41,591		—		41,591
Commercial paper		—		15,682		—		15,682
Total	$	62,849	$	84,639	$	—	$	147,488

There were no transfers between fair value measurement levels during the three and six months ended June 30, 2023.

At June 30, 2023 and December 31, 2022, the amortized cost and fair value of available-for-sale securities consist of:

			Gross		Gross
	Amortized		Unrealized		Unrealized		Estimated
	Cost		Gains		Losses		Fair Value
	(in thousands)
June 30, 2023
U.S. treasuries	$	12,133	$	—	$	(92)	$	12,041
Government agency securities		60,262		—		(208)		60,054
Corporate debt		13,108		—		(88)		13,020
Commercial paper		20,760		—		—		20,760
Total	$	106,263	$	—	$	(388)	$	105,875
December 31, 2022
U.S. treasuries	$	63,331	$	—	$	(482)	$	62,849
Government agency securities		27,464		—		(98)		27,366
Corporate debt		42,006		—		(415)		41,591
Commercial paper		15,682		—		—		15,682
Total	$	148,483	$	—	$	(995)	$	147,488

Available-for-sale securities in a loss position at June 30, 2023 and December 31, 2022 consist of:

	Continuous Loss Position				Continuous Loss Position
	for Less than 12 Months				for 12 Months or More
			Gross				Gross
	Estimated		Unrealized		Estimated		Unrealized
	Fair Value		Losses		Fair Value		Losses
		(in thousands)
June 30, 2023
U.S. treasuries	$	4,681	$	(4)	$	7,361	$	(88)
Government agency securities		60,053		(208)		—		—
Corporate debt		8,312		(21)		4,708		(67)
Total	$	73,046	$	(233)	$	12,069	$	(155)
December 31, 2022
U.S. treasuries	$	39,791	$	(84)	$	23,057	$	(398)
Government agency securities		22,528		(86)		4,838		(12)
Corporate debt		19,693		(138)		21,898		(277)
Total	$	82,012	$	(308)	$	49,793	$	(687)

The contractual maturities of securities classified as available-for-sale at June 30, 2023 were as follows:

	June 30, 2023
	Amortized		Estimated
	Cost		Fair Value
		(in thousands)
Due in one year or less	$	99,537	$	99,192
Due after one year through two years		6,726		6,683
Total	$	106,263	$	105,875

Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. There were no realized gains or losses, or unrealized losses from declines in fair value that are other than temporary, for the six months ended June 30, 2023 and 2022.

Accounts Receivable

Accounts receivable is presented net of an allowance for doubtful accounts of $1.0 million and $0.7 million at June 30, 2023 and December 31, 2022 respectively. The Company considered its current expectations of future economic conditions when estimating its allowance for doubtful accounts.

Inventories

Inventories at June 30, 2023 and December 31, 2022 consist of the following:

	June 30,		December 31,
	2023		2022
	(in thousands)
Materials	$	152,494	$	134,940
Work-in-process		80,446		68,765
Finished goods		11,530		3,203
Total	$	244,470	$	206,908

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets primarily consist of supplier deposits, prepaid value-added tax, lease deposits, prepaid insurance, prepaid licenses, and other receivables. The Company had deposits with its suppliers of $13.4 million and $9.4 million at June 30, 2023 and December 31, 2022, respectively.

Property, Plant, and Equipment

Property, plant, and equipment at June 30, 2023 and December 31, 2022 consist of the following:

	June 30,		December 31,
	2023		2022
	(in thousands)
Land	$	5,061	$	5,061
Building and improvements		64,151		64,198
Machinery and equipment (1)		166,764		155,533
Leasehold improvements		55,008		54,764
Gross property, plant, and equipment		290,984		279,556
Less: accumulated depreciation and amortization		178,991		172,275
Net property, plant, and equipment	$	111,993	$	107,281

(1) Machinery and equipment also includes software, furniture and fixtures

For the three and six months ended June 30, 2023, depreciation expense was $4.0 million and $8.2 million, respectively, and $4.0 million and $7.7 million, respectively, for the comparable 2022 periods.

Goodwill

Goodwill represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. The following table presents the changes in goodwill balances for the six months ended June 30, 2023:

	Gross carrying		Accumulated
	amount		impairment		Net amount
	(in thousands)
Balance at December 31, 2022	$	430,331	$	248,388	$	181,943
Acquisition		33,021		—		33,021
Balance at June 30, 2023	$	463,352	$	248,388	$	214,964

Intangible Assets

Intangible assets consist of purchased technology, customer relationships, patents, trademarks and tradenames, licenses, and backlog, and are initially recorded at fair value. Long-lived intangible assets are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or amortized on a straight-line basis if such pattern cannot be reliably determined. The Company continues to assess potential triggering events related to the value of its intangible assets and concluded that there were no indicators of impairment during the three and six months ended June 30, 2023.

The components of purchased intangible assets were as follows:

	June 30, 2023						December 31, 2022
			Accumulated						Accumulated
	Gross		Amortization				Gross		Amortization
	Carrying		and		Net		Carrying		and		Net
	Amount		Impairment		Amount		Amount		Impairment		Amount
	(in thousands)
Technology	$	355,928	$	319,420	$	36,508	$	327,908	$	316,918	$	10,990
Customer relationships		146,925		136,528		10,397		146,465		135,415		11,050
Trademarks and tradenames		30,910		29,666		1,244		30,910		29,063		1,847
Other		3,746		3,703		43		3,686		3,686		—
Total	$	537,509	$	489,317	$	48,192	$	508,969	$	485,082	$	23,887

Other intangible assets primarily consist of patents, licenses, and backlog.

XML

Liabilities

6 Months Ended

Jun. 30, 2023

Liabilities

Liabilities

Note 5 — Liabilities

Accrued Expenses and Other Current Liabilities

The components of accrued expenses and other current liabilities at June 30, 2023 and December 31, 2022 consist of:

	June 30,		December 31,
	2023		2022
	(in thousands)
Payroll and related benefits	$	21,358	$	30,044
Contingent consideration		9,791		—
Warranty		8,577		8,601
Operating lease liabilities		3,615		3,333
Interest		1,351		2,853
Professional fees		3,443		2,102
Sales, use, and other taxes		2,708		2,027
Other		10,980		7,071
Total	$	61,823	$	56,031

Warranty

Warranties are typically valid for one year from the date of system final acceptance. The Company estimates the costs that may be incurred under the warranty which are determined by analyzing specific product and historical configuration statistics and regional warranty support costs and are affected by product failure rates, material usage, and labor costs incurred in correcting product failures during the warranty period. Unforeseen component failures or exceptional component performance can also result in changes to warranty costs. Changes in product warranty reserves for the six months ended June 30, 2023 include:

		(in thousands)
Balance - December 31, 2022	$	8,601
Warranties issued		3,084
Addition from Epiluvac acquisition		49
Consumption of reserves		(3,484)
Changes in estimate		327
Balance - June 30, 2023	$	8,577

Customer Deposits and Deferred Revenue

Customer deposits totaled $136.6 million and $110.2 million at June 30, 2023 and December 31, 2022, respectively. Deferred revenue represents amounts billed, other than deposits, in excess of the revenue that can be recognized on a particular contract at the balance sheet date. Changes in deferred revenue were as follows:

	(in thousands)
Balance - December 31, 2022	$	16,990
Deferral of revenue		8,241
Recognition of unearned revenue		(5,111)
Balance - June 30, 2023	$	20,120

As of June 30, 2023, the Company has approximately $274.8 million of remaining performance obligations on contracts with an original estimated duration of one year or more, of which approximately 66% is expected to be recognized within one year, with the remaining amounts expected to be recognized between one to three years. The Company has elected to exclude disclosures regarding remaining performance obligations that have an original expected duration of one year or less.

Convertible Senior Notes

2023 Notes

On January 10, 2017, the Company issued $345.0 million of 2.70% convertible senior unsecured notes due 2023 (the “2023 Notes”). The Company received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The 2023 Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The 2023 Notes had a maturity date of January 15, 2023, unless earlier purchased by the Company, redeemed, or converted.

On May 18, 2020, in connection with the completion of a private offering of $125.0 million aggregate principal amount of 3.75% convertible senior notes due 2027 described below, the Company repurchased and retired approximately $88.3 million in aggregate principal amount of its outstanding 2023 Notes, with a carrying amount of $78.1 million, for approximately $81.2 million of cash.

Additionally, on November 11, 2020, the Company entered into a privately negotiated exchange agreement with a holder of its outstanding 2023 Notes, under which the Company agreed to retire $125.0 million in aggregate original principal amount of the 2023 Notes, with a carrying amount of $113.1 million, in exchange for the issuance of $132.5 million in aggregate principal amount of new 3.50% convertible senior notes due 2025 described below, which had a fair value that approximated the principal amount of new notes issued.

Finally, on November 5, 2021, the Company entered into a privately negotiated note purchase agreement with a holder of its outstanding 2023 Notes, under which the Company agreed to repurchase and retire approximately $111.5 million in aggregate original principal amount of the 2023 Notes, with a carrying amount of $105.5 million, for cash consideration of approximately $115.6 million, and approximately $1.0 million of accrued and unpaid interest.

The 2023 notes that remained outstanding matured on January 15, 2023 and were paid in cash and settled by the Company at that time.

2025 Notes

On November 17, 2020, as part of the privately negotiated exchange agreement described above, the Company issued $132.5 million of 3.50% convertible senior notes due 2025 (the “2025 Notes”). The 2025 Notes bear interest at a rate of 3.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2021. The 2025 Notes mature on January 15, 2025, unless earlier purchased by the Company, redeemed, or converted.

On May 19, 2023, in connection with the completion of a private offering of $230.0 million aggregate principal amount of 2.875% convertible senior notes due 2029 described below, the Company repurchased and retired approximately $106.0 million in aggregate principal amount of its outstanding 2025 Notes, with a carrying amount of $105.4 million, for approximately $106.0 million of cash and 0.7 million shares of the Company’s common stock. The Company accounted for the partial settlement of the 2025 Notes as an extinguishment, and as such, recorded a loss on

extinguishment of approximately $16.5 million for the three and six months ended June 30, 2023, which is included in the “Other income (expense), net” in the Consolidated Statements of Operations.

2027 Notes

On May 18, 2020, the Company completed a private offering of $125.0 million of 3.75% convertible senior notes due 2027 (the “2027 Notes”). The Company received net proceeds of approximately $121.9 million, after deducting underwriting discounts and fees and expenses payable by the Company. Additionally, the Company used approximately $10.3 million of cash to purchase capped calls, discussed below. The 2027 Notes bear interest at a rate of 3.75% per year, payable semiannually in arrears on June 1 and December 1 of each year, commencing on December 1, 2020. The 2027 Notes mature on June 1, 2027, unless earlier purchased by the Company, redeemed, or converted.

On May 19, 2023, in connection with the completion of a private offering of $230.0 million aggregate principal amount of 2.875% convertible senior notes due 2029 described below, the Company repurchased and retired approximately $100.0 million in aggregate principal amount of its outstanding 2027 Notes, with a carrying amount of $98.5 million, for approximately $92.8 million of cash and 3.8 million shares of the Company’s common stock. The Company accounted for the partial settlement of the 2027 Notes as an extinguishment, and as such, recorded a loss on extinguishment of approximately $80.6 million for the three and six months ended June 30, 2023, which is included in the “Other income (expense), net” in the Consolidated Statements of Operations.

2029 Notes

On May 19, 2023, the Company completed a private offering of $230.0 million of 2.875% convertible senior notes due 2029 (the “2029 Notes”). The Company received net proceeds of approximately $223.2 million, after deducting underwriting discounts and fees and expenses payable by the Company. Additionally, the Company used approximately $198.8 million of net proceeds from the offering to fund the cash portion of the 2025 Notes and 2027 Notes extinguishments described above and the remainder for general corporate purposes. The 2029 Notes bear interest at a rate of 2.875% per year, payable semiannually in arrears on June 1 and December 1 of each year, commencing on December 1, 2023. The 2029 Notes mature on June 1, 2029, unless earlier purchased by the Company, redeemed, or converted. The Company will settle any conversions of the 2029 Notes by paying cash up to the aggregate principal amount of the 2029 Notes to be converted, and paying or delivering either cash, shares of Company’s common stock, or a combination of cash and shares of common stock at the Company’s election, in respect of the remainder, if any, of the conversion obligation in excess of the aggregate principal amount of the 2029 Notes being converted.

The 2025 Notes, 2027 Notes, and 2029 Notes (collectively, the “Notes”) are unsecured senior obligations of Veeco and rank senior in right of payment to any of Veeco’s subordinated indebtedness; equal in right of payment to all of Veeco’s unsecured indebtedness that is not subordinated; effectively subordinated in right of payment to any of Veeco’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to all indebtedness and other liabilities (including trade payables) of Veeco’s subsidiaries.

The Notes are convertible at the option of the holders upon the satisfaction of specified conditions and during certain periods as described below. The initial conversion rates are 41.6667, 71.5372, and 34.21852 shares of the Company’s common stock per $1,000 principal amount of the 2025 Notes, 2027 Notes, and 2029 Notes, respectively, representing initial effective conversion prices of $24.00, $13.98, and $29.22 per share of common stock, respectively. The conversion rates may be subject to adjustment upon the occurrence of certain specified events.

Holders may convert all or any portion of their Notes, in multiples of one thousand dollar principal amount, at their option at any time prior to the close of business on the business day immediately preceding October 15, 2024, with

respect to the 2025 Notes, October 1, 2026, with respect to the 2027 Notes, and February 1, 2029 with respect to the 2029 Notes, only under the following circumstances:

(i) During any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

(ii) During the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollar principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;

(iii) If the Company calls any or all of applicable series of the Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or

(iv) Upon the occurrence of specified corporate events.

For the calendar quarter ended June 30, 2023, the last reported sales price of the common stock during the 30 consecutive trading days, based on the criteria outlined in (i) above, was greater than 130% of the conversion price of the 2027 Notes, and as such the 2027 Notes are convertible by the holders until September 30, 2023.

Holders may convert their Notes at any time, regardless of the foregoing circumstances, on October 15, 2024 with respect to the 2025 Notes, October 1, 2026, with respect to the 2027 Notes, and February 1, 2029, with respect to the 2029 Notes, until the close of business on the business day immediately preceding the respective maturity date.

The Notes are recorded as a single unit within liabilities in the consolidated balance sheets as the conversion features within the Notes are not derivatives that require bifurcation and the Notes do not involve a substantial premium. Transaction costs of $9.2 million, $1.9 million, $3.1 million, and $6.8 million incurred in connection with the issuance of the 2023 Notes, 2025 Notes, 2027 Notes, and 2029 Notes, respectively, were recorded as direct deductions from the related debt liabilities and recognized as non-cash interest expense using the effective interest method over the expected terms of the Notes.

The carrying value of the 2023 Notes, 2025 Notes, 2027 Notes, and 2029 Notes are as follows:

		June 30, 2023						December 31, 2022
		Principal Amount		Unamortized transaction costs		Net carrying value		Principal Amount		Unamortized debt discount/ transaction costs		Net carrying value
		(in thousands)
2023 Notes	$	—	$	—	$	—	$	20,173	$	(4)	$	20,169
2025 Notes		26,500		(149)		26,351		132,500		(990)		131,510
2027 Notes		25,000		(358)		24,642		125,000		(2,019)		122,981
2029 Notes		230,000		(6,657)		223,343		—		—		—
Net carrying value	$	281,500	$	(7,165)	$	274,335	$	277,673	$	(3,013)	$	274,660

Total interest expense related to the 2023 Notes, 2025 Notes, 2027 Notes, and 2029 Notes is as follows:

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands)
Cash Interest Expense
Coupon interest expense - 2023 Notes	$	—	$	136	$	23	$	272
Coupon interest expense - 2025 Notes		737		1,159		1,896		2,318
Coupon interest expense - 2027 Notes		745		1,172		1,917		2,344
Coupon interest expense - 2029 Notes		753		—		753		—
Non-cash Interest Expense
Amortization of debt discount/transaction costs- 2023 Notes		—		24		4		48
Amortization of debt discount/transaction costs- 2025 Notes		77		114		194		226
Amortization of debt discount/transaction costs- 2027 Notes		70		101		175		202
Amortization of debt discount/transaction costs- 2029 Notes		141		—		141		—
Total Interest Expense	$	2,523	$	2,706	$	5,103	$	5,410

The Company determined the 2025 Notes, 2027 Notes, and 2029 Notes are Level 2 liabilities in the fair value hierarchy and had an estimated fair value at June 30, 2023 of $31.9 million, $49.3 million, and $257.0 million, respectively.

Capped Call Transactions

In connection with the offering of the 2027 Notes, on May 13, 2020, the Company entered into privately negotiated capped call transactions (the “Capped Call Transactions”), pursuant to capped call confirmations, covering the total principal amount of the 2027 Notes for an aggregate premium of $10.3 million. The Capped Call Transactions are expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of the 2027 Notes and/or offset any cash payments the Company is required to make in excess of the aggregate principal amount of converted 2027 Notes, as the case may be, with such reduction and/or offset subject to a cap based on the capped price of the Capped Call Transactions. The Capped Call Transactions exercise price is equal to the initial conversion price of the 2027 Notes, and the capped price of the Capped Call Transactions is approximately $18.46 per share and is subject to certain adjustments under the terms of the capped call confirmations.

The Capped Call Transactions are separate transactions entered into by the Company with the capped call counterparties, are not part of the terms of the 2027 Notes and do not change the holders’ rights under the 2027 Notes. Holders of the 2027 Notes do not have any rights with respect to the Capped Call Transactions. The cost of the Capped Call Transactions is not expected to be tax-deductible as the Company did not elect to integrate the Capped Call Transactions into the 2027 Notes for tax purposes. The Company used a portion of the net proceeds from the offering of the 2027 Notes to pay for the Capped Call Transactions, and the cost of the Capped Call Transactions was recorded as a reduction of the Company’s additional paid-in capital in the accompanying consolidated financial statements.

Revolving Credit Facility

On December 16, 2021, the Company entered into a loan and security agreement providing for a senior secured revolving credit facility in an aggregate principal amount of $150 million (the “Credit Facility”), including a $15 million letter of credit sublimit. The Credit Facility is guaranteed by the Company’s direct material U.S. subsidiaries, subject to customary exceptions. Borrowings under the Credit Facility are secured by a first-priority lien on substantially all of the assets of the Company, subject to customary exceptions. The Credit Facility has a term of five years, maturing on December 16, 2026, or earlier if certain liquidity measures are not met prior to the 2025 Notes maturing. Subject to certain conditions and the receipt of commitments from the lenders, the Loan and Security Agreement allows for revolving commitments under the Credit Facility to be increased by up to $75 million. The existing lenders under the Credit Facility are entitled, but not obligated, to provide such incremental commitments.

Borrowings will bear interest at a floating rate which can be, at the Company’s option, either (a) an alternate base rate plus an applicable rate ranging from 0.50% to 1.25% or (b) a Secured Overnight Financing Rate (“SOFR”) (with a floor of 0.00%) for the specified interest period plus an applicable rate ranging from 1.50% to 2.25%, in each case, depending on the Company’s Secured Net Leverage Ratio (as defined in the Loan and Security Agreement). The Company will pay an unused commitment fee ranging from 0.25% to 0.35% based on unused capacity under the Credit Facility and the Company’s Secured Net Leverage Ratio. The Company may use the proceeds of borrowings under the Credit Facility to pay transaction fees and expenses, provide for its working capital needs and reimburse drawings under letters of credit and for other general corporate purposes.

The Loan and Security Agreement contains customary affirmative covenants for transactions of this type, including, among others, the provision of financial and other information to the administrative agent, notice to the administrative agent upon the occurrence of certain material events, preservation of existence, maintenance of properties and insurance, compliance with laws, including environmental laws, the provision of additional guarantees, and an affiliate transactions covenant, subject to certain exceptions. The Loan and Security Agreement contains customary negative covenants, including, among others, restrictions on the ability to merge and consolidate with other companies, incur indebtedness, refinance our existing convertible notes, grant liens or security interests on assets, make investments, acquisitions, loans, or advances, pay dividends, and sell or otherwise transfer assets.

The Loan and Security Agreement contains financial maintenance covenants that require the Borrower to maintain an Interest Coverage Ratio (as defined in the Loan and Security Agreement) of not less than 3.00 to 1.00, a Total Net Leverage Ratio (as defined in the Loan and Security Agreement) of not more than 4.50 to 1.00, and a Secured Net Leverage Ratio (as defined in the Loan and Security Agreement) of not more than 2.50 to 1.00, in each case, tested at the end of each fiscal quarter commencing with the fiscal quarter ending June 30, 2022. The Loan and Security Agreement also provides for a number of customary events of default, including, among others: payment defaults to the lenders; voluntary and involuntary bankruptcy proceedings; covenant defaults; material inaccuracies of representations and warranties; certain change of control events; material money judgments; and other customary events of default. The occurrence of an event of default could result in the acceleration of obligations and the termination of lending commitments under the Loan and Security Agreement.

No amounts were outstanding under the Credit Facility as of June 30, 2023 or December 31, 2022.

Other Liabilities

Other liabilities at June 30, 2023 and December 31, 2022 included (i) medical and dental benefits for former executives of $1.9 million and $2.0 million, respectively; (ii) asset retirement obligations of $0.9 million and $0.7 million, respectively; and (iii) contingent consideration of $16.6 million as of June 30, 2023.

XML

Commitments and Contingencies

6 Months Ended

Jun. 30, 2023

Commitments and Contingencies

Commitments and Contingencies

Note 6 — Commitments and Contingencies

Leases

The Company’s operating leases primarily include real estate leases for properties used for manufacturing, R&D activities, sales and service, and administration, as well as certain equipment leases. Some leases may include options to renew for a period of up to 5 years, while others may include options to terminate the lease. The weighted average remaining lease term of the Company’s operating leases as of June 30, 2023 was 12 years, and the weighted average discount rate used in determining the present value of future lease payments was 5.6%.

The following table provides the maturities of lease liabilities at June 30, 2023:

	Operating
	Leases
	(in thousands)
Payments due by period:
2023	$	1,748
2024		4,599
2025		4,086
2026		4,060
2027		3,629
Thereafter		34,245
Total future minimum lease payments		52,367
Less: Imputed interest		(15,914)
Total	$	36,453
Reported as of June 30, 2023
Accrued expenses and other current liabilities	$	3,615
Long-term operating lease liabilities		32,838
Total	$	36,453

Operating lease cost for the three and six months ended June 30, 2023 were $1.2 million and $2.6 million, respectively, and $1.8 million and $3.7 million, respectively, for the comparable 2022 periods. Variable lease cost for the three and six months ended June 30, 2023 were $0.2 million and $0.5 million respectively, and $0.5 million and $1.0 million, respectively, for the comparable 2022 periods. Additionally, the Company has an immaterial amount of short-term leases. Operating cash outflows from operating leases for the six months ended June 30, 2023 and 2022 were $3.0 million and $3.8 million, respectively.

Receivable Purchase Agreement

The Company entered into a receivable purchase agreement with a financial institution to sell certain of its trade receivables from customers without recourse, up to $20.0 million at any point in time. Pursuant to this agreement, the Company sold $9.9 million of receivables during the three months ended June 30, 2023, all of which remained outstanding as of June 30, 2023 as defined in the receivable purchase agreement, and $10.1 million was available under the agreement for additional sales of receivables. The Company did not sell any receivables under this agreement for the six months ended June 30, 2022. The net sale of accounts receivable under the agreement is reflected as a reduction of accounts receivable in the Company’s Consolidated Balance Sheet at the time of sale and any fees for the sale of trade receivables were not material for the periods presented.

Purchase Commitments

Veeco has purchase commitments of $235.5 million at June 30, 2023, substantially all of which become due within one year.

Bank Guarantees

Veeco has bank guarantees and letters of credit issued by a financial institution on its behalf as needed. At June 30, 2023, outstanding bank guarantees and standby letters of credit totaled $19.3 million, and unused bank guarantees and letters of credit of $12.6 million were available to be drawn upon.

Legal Proceedings

The Company is involved in various legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

XML

Stockholders' Equity

6 Months Ended

Jun. 30, 2023

Stockholders' Equity

Stockholders' Equity

Note 7 — Equity

Statement of Stockholders’ Equity

The following tables present the changes in Stockholders’ Equity:

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2022	51,660	$	517	$	1,078,180	$	(501,801)	$	928	$	577,824
Net income	—		—		—		8,741		—		8,741
Other comprehensive income (loss), net of tax	—		—		—		—		476		476
Share-based compensation expense	—		—		7,027		—		—		7,027
Net issuance under employee stock plans	33		—		(8,509)		—		—		(8,509)
Balance at March 31, 2023	51,693	$	517	$	1,076,698	$	(493,060)	$	1,404	$	585,559
Net income	—		—		—		(85,320)		—		(85,320)
Other comprehensive income (loss), net of tax	—		—		—		—		(39)		(39)
Share-based compensation expense	—		—		7,932		—		—		7,932
Partial extinguishment of 2025 and 2027 Notes	4,460		45		102,095						102,140
Net issuance under employee stock plans	185		2		2,326		—		—		2,328
Balance at June 30, 2023	56,338	$	564	$	1,189,051	$	(578,380)	$	1,365	$	612,600

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2021	50,653	$	507	$	1,116,921	$	(681,283)	$	1,483	$	437,628
Cumulative effect of change in accounting principle - adoption of ASU 2020-06	—		—		(56,801)		12,541		—		(44,260)
Net income	—		—		—		13,330		—		13,330
Other comprehensive income (loss), net of tax	—		—		—		—		(822)		(822)
Share-based compensation expense	—		—		4,481		—		—		4,481
Net issuance under employee stock plans	590		6		(6,793)		—		—		(6,787)
Balance at March 31, 2022	51,243	$	513	$	1,057,808	$	(655,412)	$	661	$	403,570
Net income	—		—		—		9,655		—		9,655
Other comprehensive income (loss), net of tax	—		—		—		—		(272)		(272)
Share-based compensation expense	—		—		6,278		—		—		6,278
Net issuance under employee stock plans	182		2		1,504		—		—		1,506
Balance at June 30, 2022	51,425	$	515	$	1,065,590	$	(645,757)	$	389	$	420,737

Accumulated Other Comprehensive Income (“AOCI”)

The following table presents the changes in the balances of each component of AOCI, net of tax:

			Unrealized
			Gains (Losses)
	Foreign		on Available
	Currency		for Sale
	Translation		Securities		Total
	(in thousands)
Balance - December 31, 2022	$	1,773	$	(845)	$	928
Other comprehensive income (loss)		(33)		470		437
Balance - June 30, 2023	$	1,740	$	(375)	$	1,365

There were minimal reclassifications from AOCI into net income for the three and six months ended June 30, 2023 and 2022.

XML

Share-based Compensation

6 Months Ended

Jun. 30, 2023

Share-based Compensation

Share-based compensation

Note 8 — Share-based Compensation

Restricted share awards are issued to employees and to members of our board of directors that are subject to specified restrictions and a risk of forfeiture. The restrictions typically lapse over one to four years and may entitle holders to dividends and voting rights. Other types of share-based compensation include performance share awards, performance share units, and restricted share units (collectively with restricted share awards, “restricted shares”), as well as options to purchase common stock.

Share-based compensation expense was recognized in the following line items in the Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022:

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands)
Cost of sales	$	1,572	$	1,251	$	3,023	$	2,189
Research and development		2,568		1,863		4,657		3,120
Selling, general, and administrative		3,792		3,164		7,279		5,450
Total	$	7,932	$	6,278	$	14,959	$	10,759

For the six months ended June 30, 2023, equity activity related to stock options was as follows:

		Weighted
	Number of	Average
	Shares	Exercise Price
	(in thousands)
Balance - December 31, 2022	177	$	30.94
Expired	(62)		30.47
Balance - June 30, 2023	115		31.18

For the six months ended June 30, 2023, equity activity related to non-vested restricted shares and performance shares was as follows:

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
	(in thousands)
Balance - December 31, 2022	2,496	$	23.83
Granted	1,076		22.79
Performance award adjustments	183		10.59
Vested	(1,113)		16.47
Forfeited	(50)		28.01
Balance - June 30, 2023	2,592		25.66

XML

Income Taxes

6 Months Ended

Jun. 30, 2023

Income Taxes

Income Taxes

Note 9 — Income Taxes

Income taxes are estimated for each of the jurisdictions in which the Company operates. Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. Realization of net deferred tax assets is dependent on future taxable income.

At the end of each interim reporting period, the effective tax rate is aligned with expectations for the full year. This estimate is used to determine the income tax provision on a year-to-date basis and may change in subsequent interim periods.

Income before income taxes and income tax expense (benefit) for the three and six months ended June 30, 2023 and 2022 were as follows:

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands, except percentages)
Income (loss) before income taxes	$	(84,035)	$	10,188	$	(75,031)	$	23,902
Income tax expense (benefit)	$	1,285	$	533	$	1,548	$	917
Effective tax rate		(1.53)%		5.23%		(2.06)%		3.84%

The Company’s tax expense for the three and six months ended June 30, 2023 was $1.3 million and $1.5 million respectively, compared to $0.5 million and $0.9 for the comparable prior periods. For the three and six months ended June 30, 2023, the Company’s income tax expense primarily related to pre-tax income from operations excluding the loss on extinguishment of the 2025 and 2027 Notes. Pursuant to the limitation on losses from extinguishment of convertible notes under Section 249 of the Internal Revenue Code of 1986, as amended (Section 249), the Company recognized a benefit of $0.9 million associated with this loss for the three and six months ended June 30, 2023. Additionally, the income tax expense for the three and six months ended June 30, 2023 was favorably impacted by the tax benefits related to Foreign-Derived Intangible Income and research and development tax credits, as well as discrete income tax benefit for share-based compensation windfall. For the three and six months ended June 30, 2022, the effective tax rate was lower than the U.S. statutory tax rate primarily related to changes in the valuation allowance of deferred tax assets in the U.S.

XML

Segment Reporting and Geographic Information

6 Months Ended

Jun. 30, 2023

Segment Reporting and Geographic Information

Segment Reporting and Geographic Information

Note 10 — Segment Reporting and Geographic Information

Veeco operates and measures its results in one operating segment and therefore has one reportable segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make electronic devices.

Veeco serves the following four end-markets:

Semiconductor

The Semiconductor market refers to early process steps in logic and memory applications where silicon wafers are processed. There are many different process steps in forming patterned wafers, such as deposition, etching, masking, and doping, where the microchips are created but remain on the silicon wafer. This market includes mask blank production for extreme ultraviolet (“EUV”) lithography, as well as Advanced Packaging, which refers to a portfolio of wafer-level assembly technologies that enable improved performance of electronic products, such as smartphones, high-end servers, and graphical processors.

Compound Semiconductor

The Compound Semiconductor market includes Photonics, Power Electronics, RF Filters and Amplifiers, and Solar applications. Photonics refers to light source technologies and laser-based solutions for 3D sensing, datacom and telecom applications. This includes micro-LED, laser diodes, edge emitting lasers and vertical cavity surface emitting lasers (“VCSELs”). Power Electronics refers to semiconductor devices such as rectifiers, inverters and converters for the control and conversion of electric power in applications such as fast or wireless charging of consumer electronics and automotive applications. RF power amplifiers and filters (including surface acoustic wave (“SAW”) and bulk acoustic wave (“BAW”) filters) are used in 5G communications infrastructure, smartphones, tablets, and mobile devices. They make use of radio waves for wireless broadcasting and/or communications. Solar refers to power obtained by harnessing the energy of the sun through the use of compound semiconductor devices such as photovoltaics.

Data Storage

Data Storage refers to the Hard Disk Drive (“HDD”) market, for which our systems enable customers to manufacture thin film magnetic heads for hard disk drives as part of large capacity storage applications.

Scientific & Other

Scientific & Other refers to advanced materials research and a range of manufacturing applications including optical coatings (laser mirrors, optical filters, and anti-reflective coatings).

Sales by end-market and geographic region for the three and six months ended June 30, 2023 and 2022 were as follows:

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands)
Sales by end-market
Semiconductor	$	106,275	$	97,521	$	199,382	$	175,141
Compound Semiconductor		24,066		31,122		45,225		68,231
Data Storage		13,945		21,548		35,459		43,143
Scientific & Other		17,355		13,808		35,079		33,910
Total	$	161,641	$	163,999	$	315,145	$	320,425
Sales by geographic region
United States	$	35,739	$	57,940	$	66,750	$	105,410
EMEA(1)		17,511		27,234		40,458		48,660
China		49,986		28,497		110,733		58,878
Rest of APAC		58,320		49,345		97,065		106,267
Rest of World		85		983		139		1,210
Total	$	161,641	$	163,999	$	315,145	$	320,425

(1) EMEA consists of Europe, the Middle East, and Africa

For geographic reporting, sales are attributed to the location in which the customer facility is located.

XML

Basis of Presentation (Policies)

6 Months Ended

Jun. 30, 2023

Basis of Presentation

Basis of Presentation

The accompanying unaudited Consolidated Financial Statements of Veeco have been prepared in accordance with U.S. GAAP as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 270 for interim financial information and with the instructions to Rule 10-01 of Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements as the interim information is an update of the information that was presented in Veeco’s most recent annual financial statements. For further information, refer to Veeco’s Consolidated Financial Statements and Notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2022 (“2022 Form 10-K”). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal, recurring nature.

Fiscal Period

Veeco reports interim quarters on a 13-week basis ending on the last Sunday of each quarter. The fourth quarter always ends on the last day of the calendar year, December 31. The 2023 interim quarters end on April 2, July 2, and October 1, and the 2022 interim quarters ended on April 3, July 3, and October 2. These interim quarters are reported as March 31, June 30, and September 30 in Veeco’s interim consolidated financial statements.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, actual results may differ from these estimates.

Revenue Recognition

Revenue Recognition

Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, the Company estimates the amount of variable consideration and determines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another.

When there are separate units of accounting, the Company allocates revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items that are not sold separately, the Company estimates stand-alone selling prices generally using an expected cost plus margin approach.

Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in the Company’s facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed

internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. The Company recognizes such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

In certain cases the Company’s contracts with customers contain a billing retention, which is billed by the Company and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets.

The Company recognizes revenue related to maintenance and service contracts over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or generally expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred since the expected amortization period is one year or less.

The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in cost of sales when the Company recognizes revenue for the related goods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue.

Inventories

Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for the Company’s products may require a write down of inventory, which would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition.

XML

Income Per Common Share (Tables)

6 Months Ended

Jun. 30, 2023

Income Per Common Share

Schedule of computations of basic and diluted income per share

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands, except per share amounts)
Numerator:
Net income (loss)	$	(85,320)	$	9,655	$	(76,579)	$	22,985
Interest expense associated with convertible notes		—		1,273		—		2,546
Net income (loss) available to common shareholders	$	(85,320)	$	10,928	$	(76,579)	$	25,531
Denominator:
Basic weighted average shares outstanding		52,861		49,697		51,764		49,702
Effect of potentially dilutive share-based awards		—		816		—		877
Dilutive effect of convertible notes		—		8,942		—		8,942
Diluted weighted average shares outstanding		52,861		59,455		51,764		59,521
Net income per common share:
Basic	$	(1.61)	$	0.19	$	(1.48)	$	0.46
Diluted	$	(1.61)	$	0.18	$	(1.48)	$	0.43
Common share equivalents excluded from the diluted weighted average shares outstanding since the Company incurred a net loss and their effect would be antidilutive		838		N/A		674		N/A
Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive		743		987		763		645
Potential shares to be issued for settlement of the convertible notes excluded from the diluted calculation as their effect would be antidilutive		8,868		6,025		11,722		6,025

XML

Business Combination (Tables)

6 Months Ended

Jun. 30, 2023

Business Combination

Schedule of acquisition date fair value of consideration

	Acquisition Date
	(January 31, 2023)
	(in thousands)
Cash paid, net of cash acquired	$	30,373
Contingent consideration		26,055
Acquisition date fair value	$	56,428

Summary of estimated fair values of assets acquired and liabilities assumed

	Acquisition Date
	(January 31, 2023)
	(in thousands)
Accounts receivable	$	247
Inventories		391
Prepaid expense and other current assets		381
Property, plant, and equipment		736
Intangible assets		28,540
Total identifiable assets acquired		30,295
Accounts payable and accrued expenses		656
Customer deposits and deferred revenue		429
Deferred income taxes		5,723
Other liabilities		80
Total liabilities assumed		6,888
Net identifiable assets acquired		23,407
Goodwill		33,021
Net assets acquired	$	56,428

Summary of classes of intangible assets acquired and estimated useful life

	Acquisition Date
	(January 31, 2023)
	Amount		Useful life
	(in thousands)
Technology	$	28,020	15	years
Customer relationships		460	5	years
Backlog		60	1.5	years
Intangible assets acquired	$	28,540

XML

Assets (Tables)

6 Months Ended

Jun. 30, 2023

Assets

Schedule of portion of Veeco's assets (excluding cash balances) that are measured at fair value on a recurring basis

	Level 1		Level 2		Level 3		Total
	(in thousands)
June 30, 2023
Cash equivalents
Certificate of deposits and time deposits	$	57,432	$	—	$	—	$	57,432
Commercial paper		—		11,475		—		11,475
Money market cash		50,846		—		—		50,846
Total	$	108,278	$	11,475	$	—	$	119,753
Short-term investments
U.S. treasuries	$	12,041	$	—	$	—	$	12,041
Government agency securities		—		60,054		—		60,054
Corporate debt		—		13,020		—		13,020
Commercial paper		—		20,760		—		20,760
Total	$	12,041	$	93,834	$	—	$	105,875
December 31, 2022
Cash equivalents
Certificate of deposits and time deposits	$	61,135	$	—	$	—	$	61,135
Money market cash		405		—		—		405
Total	$	61,540	$	—	$	—	$	61,540
Short-term investments
U.S. treasuries	$	62,849	$	—	$	—	$	62,849
Government agency securities		—		27,366		—		27,366
Corporate debt		—		41,591		—		41,591
Commercial paper		—		15,682		—		15,682
Total	$	62,849	$	84,639	$	—	$	147,488

Schedule of amortized cost and fair value of available-for-sale securities

			Gross		Gross
	Amortized		Unrealized		Unrealized		Estimated
	Cost		Gains		Losses		Fair Value
	(in thousands)
June 30, 2023
U.S. treasuries	$	12,133	$	—	$	(92)	$	12,041
Government agency securities		60,262		—		(208)		60,054
Corporate debt		13,108		—		(88)		13,020
Commercial paper		20,760		—		—		20,760
Total	$	106,263	$	—	$	(388)	$	105,875
December 31, 2022
U.S. treasuries	$	63,331	$	—	$	(482)	$	62,849
Government agency securities		27,464		—		(98)		27,366
Corporate debt		42,006		—		(415)		41,591
Commercial paper		15,682		—		—		15,682
Total	$	148,483	$	—	$	(995)	$	147,488

Schedule of fair value and unrealized losses of available-for-sale securities in a loss position

	Continuous Loss Position				Continuous Loss Position
	for Less than 12 Months				for 12 Months or More
			Gross				Gross
	Estimated		Unrealized		Estimated		Unrealized
	Fair Value		Losses		Fair Value		Losses
		(in thousands)
June 30, 2023
U.S. treasuries	$	4,681	$	(4)	$	7,361	$	(88)
Government agency securities		60,053		(208)		—		—
Corporate debt		8,312		(21)		4,708		(67)
Total	$	73,046	$	(233)	$	12,069	$	(155)
December 31, 2022
U.S. treasuries	$	39,791	$	(84)	$	23,057	$	(398)
Government agency securities		22,528		(86)		4,838		(12)
Corporate debt		19,693		(138)		21,898		(277)
Total	$	82,012	$	(308)	$	49,793	$	(687)

Schedule of contractual maturities of securities classified as available-for-sale

	June 30, 2023
	Amortized		Estimated
	Cost		Fair Value
		(in thousands)
Due in one year or less	$	99,537	$	99,192
Due after one year through two years		6,726		6,683
Total	$	106,263	$	105,875

Schedule of inventories

	June 30,		December 31,
	2023		2022
	(in thousands)
Materials	$	152,494	$	134,940
Work-in-process		80,446		68,765
Finished goods		11,530		3,203
Total	$	244,470	$	206,908

Schedule of property, plant, and equipment

	June 30,		December 31,
	2023		2022
	(in thousands)
Land	$	5,061	$	5,061
Building and improvements		64,151		64,198
Machinery and equipment (1)		166,764		155,533
Leasehold improvements		55,008		54,764
Gross property, plant, and equipment		290,984		279,556
Less: accumulated depreciation and amortization		178,991		172,275
Net property, plant, and equipment	$	111,993	$	107,281

(1) Machinery and equipment also includes software, furniture and fixtures

Schedule of changes in goodwill

	Gross carrying		Accumulated
	amount		impairment		Net amount
	(in thousands)
Balance at December 31, 2022	$	430,331	$	248,388	$	181,943
Acquisition		33,021		—		33,021
Balance at June 30, 2023	$	463,352	$	248,388	$	214,964

Schedule of intangible assets excluding goodwill

	June 30, 2023						December 31, 2022
			Accumulated						Accumulated
	Gross		Amortization				Gross		Amortization
	Carrying		and		Net		Carrying		and		Net
	Amount		Impairment		Amount		Amount		Impairment		Amount
	(in thousands)
Technology	$	355,928	$	319,420	$	36,508	$	327,908	$	316,918	$	10,990
Customer relationships		146,925		136,528		10,397		146,465		135,415		11,050
Trademarks and tradenames		30,910		29,666		1,244		30,910		29,063		1,847
Other		3,746		3,703		43		3,686		3,686		—
Total	$	537,509	$	489,317	$	48,192	$	508,969	$	485,082	$	23,887

XML

Liabilities (Tables)

6 Months Ended

Jun. 30, 2023

Liabilities

Schedule of accrued expenses and other current liabilities

	June 30,		December 31,
	2023		2022
	(in thousands)
Payroll and related benefits	$	21,358	$	30,044
Contingent consideration		9,791		—
Warranty		8,577		8,601
Operating lease liabilities		3,615		3,333
Interest		1,351		2,853
Professional fees		3,443		2,102
Sales, use, and other taxes		2,708		2,027
Other		10,980		7,071
Total	$	61,823	$	56,031

Schedule of changes in product warranty reserves

		(in thousands)
Balance - December 31, 2022	$	8,601
Warranties issued		3,084
Addition from Epiluvac acquisition		49
Consumption of reserves		(3,484)
Changes in estimate		327
Balance - June 30, 2023	$	8,577

Schedule of changes in deferred revenue

	(in thousands)
Balance - December 31, 2022	$	16,990
Deferral of revenue		8,241
Recognition of unearned revenue		(5,111)
Balance - June 30, 2023	$	20,120

Schedule of carrying value of Convertible Senior Notes

		June 30, 2023						December 31, 2022
		Principal Amount		Unamortized transaction costs		Net carrying value		Principal Amount		Unamortized debt discount/ transaction costs		Net carrying value
		(in thousands)
2023 Notes	$	—	$	—	$	—	$	20,173	$	(4)	$	20,169
2025 Notes		26,500		(149)		26,351		132,500		(990)		131,510
2027 Notes		25,000		(358)		24,642		125,000		(2,019)		122,981
2029 Notes		230,000		(6,657)		223,343		—		—		—
Net carrying value	$	281,500	$	(7,165)	$	274,335	$	277,673	$	(3,013)	$	274,660

Schedule of interest expense related to Convertible Senior Notes

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands)
Cash Interest Expense
Coupon interest expense - 2023 Notes	$	—	$	136	$	23	$	272
Coupon interest expense - 2025 Notes		737		1,159		1,896		2,318
Coupon interest expense - 2027 Notes		745		1,172		1,917		2,344
Coupon interest expense - 2029 Notes		753		—		753		—
Non-cash Interest Expense
Amortization of debt discount/transaction costs- 2023 Notes		—		24		4		48
Amortization of debt discount/transaction costs- 2025 Notes		77		114		194		226
Amortization of debt discount/transaction costs- 2027 Notes		70		101		175		202
Amortization of debt discount/transaction costs- 2029 Notes		141		—		141		—
Total Interest Expense	$	2,523	$	2,706	$	5,103	$	5,410

XML

Commitments and Contingencies (Tables)

6 Months Ended

Jun. 30, 2023

Commitments and Contingencies

Schedule of maturities of lease liabilities 2020

The following table provides the maturities of lease liabilities at June 30, 2023:

	Operating
	Leases
	(in thousands)
Payments due by period:
2023	$	1,748
2024		4,599
2025		4,086
2026		4,060
2027		3,629
Thereafter		34,245
Total future minimum lease payments		52,367
Less: Imputed interest		(15,914)
Total	$	36,453
Reported as of June 30, 2023
Accrued expenses and other current liabilities	$	3,615
Long-term operating lease liabilities		32,838
Total	$	36,453

XML

Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2023

Stockholders' Equity

Schedule of Stockholders' Equity

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2022	51,660	$	517	$	1,078,180	$	(501,801)	$	928	$	577,824
Net income	—		—		—		8,741		—		8,741
Other comprehensive income (loss), net of tax	—		—		—		—		476		476
Share-based compensation expense	—		—		7,027		—		—		7,027
Net issuance under employee stock plans	33		—		(8,509)		—		—		(8,509)
Balance at March 31, 2023	51,693	$	517	$	1,076,698	$	(493,060)	$	1,404	$	585,559
Net income	—		—		—		(85,320)		—		(85,320)
Other comprehensive income (loss), net of tax	—		—		—		—		(39)		(39)
Share-based compensation expense	—		—		7,932		—		—		7,932
Partial extinguishment of 2025 and 2027 Notes	4,460		45		102,095						102,140
Net issuance under employee stock plans	185		2		2,326		—		—		2,328
Balance at June 30, 2023	56,338	$	564	$	1,189,051	$	(578,380)	$	1,365	$	612,600

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2021	50,653	$	507	$	1,116,921	$	(681,283)	$	1,483	$	437,628
Cumulative effect of change in accounting principle - adoption of ASU 2020-06	—		—		(56,801)		12,541		—		(44,260)
Net income	—		—		—		13,330		—		13,330
Other comprehensive income (loss), net of tax	—		—		—		—		(822)		(822)
Share-based compensation expense	—		—		4,481		—		—		4,481
Net issuance under employee stock plans	590		6		(6,793)		—		—		(6,787)
Balance at March 31, 2022	51,243	$	513	$	1,057,808	$	(655,412)	$	661	$	403,570
Net income	—		—		—		9,655		—		9,655
Other comprehensive income (loss), net of tax	—		—		—		—		(272)		(272)
Share-based compensation expense	—		—		6,278		—		—		6,278
Net issuance under employee stock plans	182		2		1,504		—		—		1,506
Balance at June 30, 2022	51,425	$	515	$	1,065,590	$	(645,757)	$	389	$	420,737

Schedule of the changes in the balances of each component of AOCI, net of tax

			Unrealized
			Gains (Losses)
	Foreign		on Available
	Currency		for Sale
	Translation		Securities		Total
	(in thousands)
Balance - December 31, 2022	$	1,773	$	(845)	$	928
Other comprehensive income (loss)		(33)		470		437
Balance - June 30, 2023	$	1,740	$	(375)	$	1,365

XML

Share-based Compensation (Tables)

6 Months Ended

Jun. 30, 2023

Share-based Compensation

Schedule of share-based compensation expense

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands)
Cost of sales	$	1,572	$	1,251	$	3,023	$	2,189
Research and development		2,568		1,863		4,657		3,120
Selling, general, and administrative		3,792		3,164		7,279		5,450
Total	$	7,932	$	6,278	$	14,959	$	10,759

Summary of stock option activity

		Weighted
	Number of	Average
	Shares	Exercise Price
	(in thousands)
Balance - December 31, 2022	177	$	30.94
Expired	(62)		30.47
Balance - June 30, 2023	115		31.18

Summary of non-vested restricted and performance shares activity

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
	(in thousands)
Balance - December 31, 2022	2,496	$	23.83
Granted	1,076		22.79
Performance award adjustments	183		10.59
Vested	(1,113)		16.47
Forfeited	(50)		28.01
Balance - June 30, 2023	2,592		25.66

XML

Income Taxes (Tables)

6 Months Ended

Jun. 30, 2023

Income Taxes

Schedule of income before income taxes and income tax expense (benefit)

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands, except percentages)
Income (loss) before income taxes	$	(84,035)	$	10,188	$	(75,031)	$	23,902
Income tax expense (benefit)	$	1,285	$	533	$	1,548	$	917
Effective tax rate		(1.53)%		5.23%		(2.06)%		3.84%

XML

Segment Reporting and Geographic Information (Tables)

6 Months Ended

Jun. 30, 2023

Segment Reporting and Geographic Information

Schedule of sales by end-market

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands)
Sales by end-market
Semiconductor	$	106,275	$	97,521	$	199,382	$	175,141
Compound Semiconductor		24,066		31,122		45,225		68,231
Data Storage		13,945		21,548		35,459		43,143
Scientific & Other		17,355		13,808		35,079		33,910
Total	$	161,641	$	163,999	$	315,145	$	320,425
Sales by geographic region
United States	$	35,739	$	57,940	$	66,750	$	105,410
EMEA(1)		17,511		27,234		40,458		48,660
China		49,986		28,497		110,733		58,878
Rest of APAC		58,320		49,345		97,065		106,267
Rest of World		85		983		139		1,210
Total	$	161,641	$	163,999	$	315,145	$	320,425

(1) EMEA consists of Europe, the Middle East, and Africa

Schedule of sales by geographic region

	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
	(in thousands)
Sales by end-market
Semiconductor	$	106,275	$	97,521	$	199,382	$	175,141
Compound Semiconductor		24,066		31,122		45,225		68,231
Data Storage		13,945		21,548		35,459		43,143
Scientific & Other		17,355		13,808		35,079		33,910
Total	$	161,641	$	163,999	$	315,145	$	320,425
Sales by geographic region
United States	$	35,739	$	57,940	$	66,750	$	105,410
EMEA(1)		17,511		27,234		40,458		48,660
China		49,986		28,497		110,733		58,878
Rest of APAC		58,320		49,345		97,065		106,267
Rest of World		85		983		139		1,210
Total	$	161,641	$	163,999	$	315,145	$	320,425

(1) EMEA consists of Europe, the Middle East, and Africa

XML

Basis of Presentation - Fiscal Period (Details)	6 Months Ended
	Jun. 30, 2023
Basis of Presentation
Fiscal period duration (in days)	91 days

XML

Basis of Presentation - Revenue Recognition (Details)	6 Months Ended
	Jun. 30, 2023
Basis of Presentation
Revenue, practical expedient, incremental cost of obtaining contract	true

XML

Income Per Common Share - Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Numerator:
Net income (loss)	$ (85,320)	$ 9,655	$ (76,579)	$ 22,985
Interest expense associated with convertible notes		1,273		2,546
Net income (loss) available to common shareholders	$ (85,320)	$ 10,928	$ (76,579)	$ 25,531
Denominator:
Basic weighted average shares outstanding	52,861	49,697	51,764	49,702
Effect of potentially dilutive share-based awards		816		877
Dilutive effect of convertible notes		8,942		8,942
Diluted weighted average shares outstanding	52,861	59,455	51,764	59,521
Net income (loss) per common share:
Basic (in dollars per share)	$ (1.61)	$ 0.19	$ (1.48)	$ 0.46
Diluted (in dollars per share)	$ (1.61)	$ 0.18	$ (1.48)	$ 0.43

XML

Income Per Common Share - Shares Excluded from EPS (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Common share equivalents
Diluted income (loss) per share
Securities excluded from the diluted calculation as their effect would be antidilutive	838		674
Potentially dilutive shares
Diluted income (loss) per share
Securities excluded from the diluted calculation as their effect would be antidilutive	743	987	763	645
Convertible Notes
Diluted income (loss) per share
Securities excluded from the diluted calculation as their effect would be antidilutive	8,868	6,025	11,722	6,025

XML

Business Combination - Consideration (Details) $ in Thousands		3 Months Ended
	Jan. 31, 2023 USD ($)	Jun. 30, 2023 USD ($)
Business Combination
Contingent consideration, Accrued expenses and other current liabilities		$ 9,791
Other liabilities
Business Combination
Contingent consideration, Other liabilities		16,600
Epiluvac AB
Business Combination
Cash paid, net of cash acquired	$ 30,373
Contingent consideration	26,055
Acquisition date fair value	56,428
Contingent consideration	$ 26,100	26,400
Additional contingent consideration recognized		$ 300
Contingent consideration measurement input	0.0554
Business Combination, Contingent Consideration, Liability, Measurement Input	us-gaap:MeasurementInputDiscountRateMember
Epiluvac AB | Accrued expenses and other current liabilities
Business Combination
Contingent consideration, Accrued expenses and other current liabilities	$ 9,800
Epiluvac AB | Other liabilities
Business Combination
Contingent consideration, Other liabilities	16,600
Epiluvac AB | Completion of certain defined milestones
Business Combination
Contingent consideration payments, High end of range	15,000
Epiluvac AB | Percentage of orders received during defined Earn-out period
Business Combination
Contingent consideration payments, High end of range	$ 20,000
Maximum earn-out period	4 years

XML

Business Combination - Assets acquired and liabilities assumed (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Jan. 31, 2023	Dec. 31, 2022
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]
Goodwill	$ 214,964		$ 181,943
Epiluvac AB
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]
Accounts receivable		$ 247
Inventories		391
Prepaid expense and other current assets		381
Property, plant, and equipment		736
Intangible assets		28,540
Total identifiable assets acquired		30,295
Accounts payable and accrued expenses		656
Customer deposits and deferred revenue		429
Deferred income taxes		5,723
Other liabilities		80
Total liabilities assumed		6,888
Net identifiable assets acquired		23,407
Goodwill		33,021
Net assets acquired		$ 56,428

XML

Business Combination - Intangible assets acquired (Details) - Epiluvac AB - USD ($) $ in Thousands		3 Months Ended	6 Months Ended
	Jan. 31, 2023	Jun. 30, 2023	Jun. 30, 2023
Intangible assets
Intangible assets acquired, Amount	$ 28,540
Acquisition related costs		$ 200	$ 900
Technology
Intangible assets
Intangible assets acquired, Amount	$ 28,020
Intangible assets acquired, Useful life	15 years
Customer relationship
Intangible assets
Intangible assets acquired, Amount	$ 460
Intangible assets acquired, Useful life	5 years
Backlog
Intangible assets
Intangible assets acquired, Amount	$ 60
Intangible assets acquired, Useful life	1 year 6 months

XML

Assets - Fair Value (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Short-term investments
Transfer of assets from Level 1 to Level 2	$ 0
Transfer of assets from Level 2 to Level 1	0
Measured on a recurring basis
Cash equivalents
Total Cash equivalents	119,753	$ 61,540
Short-term investments
Total Short-term investments	105,875	147,488
Measured on a recurring basis | U.S. treasuries
Short-term investments
Total Short-term investments	12,041	62,849
Measured on a recurring basis | Government agency securities, Cash equivalents
Short-term investments
Total Short-term investments	60,054	27,366
Measured on a recurring basis | Corporate debt
Short-term investments
Total Short-term investments	13,020	41,591
Measured on a recurring basis | Commercial paper
Short-term investments
Total Short-term investments	20,760	15,682
Measured on a recurring basis | Certificate of deposits and time deposits
Cash equivalents
Total Cash equivalents	57,432	61,135
Measured on a recurring basis | Commercial paper
Cash equivalents
Total Cash equivalents	11,475
Measured on a recurring basis | Money market cash
Cash equivalents
Total Cash equivalents	50,846	405
Measured on a recurring basis | Level 1
Cash equivalents
Total Cash equivalents	108,278	61,540
Short-term investments
Total Short-term investments	12,041	62,849
Measured on a recurring basis | Level 1 | U.S. treasuries
Short-term investments
Total Short-term investments	12,041	62,849
Measured on a recurring basis | Level 1 | Certificate of deposits and time deposits
Cash equivalents
Total Cash equivalents	57,432	61,135
Measured on a recurring basis | Level 1 | Money market cash
Cash equivalents
Total Cash equivalents	50,846	405
Measured on a recurring basis | Level 2
Cash equivalents
Total Cash equivalents	11,475
Short-term investments
Total Short-term investments	93,834	84,639
Measured on a recurring basis | Level 2 | Government agency securities, Cash equivalents
Short-term investments
Total Short-term investments	60,054	27,366
Measured on a recurring basis | Level 2 | Corporate debt
Short-term investments
Total Short-term investments	13,020	41,591
Measured on a recurring basis | Level 2 | Commercial paper
Short-term investments
Total Short-term investments	20,760	$ 15,682
Measured on a recurring basis | Level 2 | Commercial paper
Cash equivalents
Total Cash equivalents	$ 11,475

XML

Assets - Available-For-Sale Securities (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Total available-for-sale securities
Amortized Cost	$ 106,263		$ 148,483
Gross Unrealized Losses	(388)		(995)
Estimated Fair Value	105,875		147,488
Available-for-sale securities in a loss position
Investments, Continuous loss position for less than 12 months, Estimated Fair Value	73,046		82,012
Investments, Continuous loss position for less than 12 months, Gross Unrealized Losses	(233)		(308)
Investments, Continuous loss position for 12 months or more, Estimated Fair Value	12,069		49,793
Investments, Continuous loss position for 12 months or more, Gross Unrealized Losses	(155)		(687)
Contractual maturities - Amortized Cost
Amortized Cost, Due in one year or less	99,537
Amortized Cost, Due after one year through two years	6,726
Amortized Cost	106,263		148,483
Contractual maturities - Estimated Fair Value
Estimated Fair Value, Due in one year or less	99,192
Estimated Fair Value, Due after one year through two years	6,683
Available-for-sale Securities, Debt Securities, Total	105,875		147,488
Realized gains or losses
Realized gains or losses	0	$ 0
Unrealized losses	0	$ 0
U.S. treasuries
Total available-for-sale securities
Amortized Cost	12,133		63,331
Gross Unrealized Losses	(92)		(482)
Estimated Fair Value	12,041		62,849
Available-for-sale securities in a loss position
Investments, Continuous loss position for less than 12 months, Estimated Fair Value	4,681		39,791
Investments, Continuous loss position for less than 12 months, Gross Unrealized Losses	(4)		(84)
Investments, Continuous loss position for 12 months or more, Estimated Fair Value	7,361		23,057
Investments, Continuous loss position for 12 months or more, Gross Unrealized Losses	(88)		(398)
Contractual maturities - Amortized Cost
Amortized Cost	12,133		63,331
Contractual maturities - Estimated Fair Value
Available-for-sale Securities, Debt Securities, Total	12,041		62,849
Government agency securities, Cash equivalents
Total available-for-sale securities
Amortized Cost	60,262		27,464
Gross Unrealized Losses	(208)		(98)
Estimated Fair Value	60,054		27,366
Available-for-sale securities in a loss position
Investments, Continuous loss position for less than 12 months, Estimated Fair Value	60,053		22,528
Investments, Continuous loss position for less than 12 months, Gross Unrealized Losses	(208)		(86)
Investments, Continuous loss position for 12 months or more, Estimated Fair Value			4,838
Investments, Continuous loss position for 12 months or more, Gross Unrealized Losses			(12)
Contractual maturities - Amortized Cost
Amortized Cost	60,262		27,464
Contractual maturities - Estimated Fair Value
Available-for-sale Securities, Debt Securities, Total	60,054		27,366
Corporate debt
Total available-for-sale securities
Amortized Cost	13,108		42,006
Gross Unrealized Losses	(88)		(415)
Estimated Fair Value	13,020		41,591
Available-for-sale securities in a loss position
Investments, Continuous loss position for less than 12 months, Estimated Fair Value	8,312		19,693
Investments, Continuous loss position for less than 12 months, Gross Unrealized Losses	(21)		(138)
Investments, Continuous loss position for 12 months or more, Estimated Fair Value	4,708		21,898
Investments, Continuous loss position for 12 months or more, Gross Unrealized Losses	(67)		(277)
Contractual maturities - Amortized Cost
Amortized Cost	13,108		42,006
Contractual maturities - Estimated Fair Value
Available-for-sale Securities, Debt Securities, Total	13,020		41,591
Commercial paper
Total available-for-sale securities
Amortized Cost	20,760		15,682
Estimated Fair Value	20,760		15,682
Contractual maturities - Amortized Cost
Amortized Cost	20,760		15,682
Contractual maturities - Estimated Fair Value
Available-for-sale Securities, Debt Securities, Total	$ 20,760		$ 15,682

XML

Assets - Accounts Receivable (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Assets
Allowance for doubtful accounts receivable	$ 1.0	$ 0.7

XML

Assets - Inventories (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Inventories
Materials	$ 152,494	$ 134,940
Work-in-process	80,446	68,765
Finished goods	11,530	3,203
Total	$ 244,470	$ 206,908

XML

Assets - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Prepaid expenses and other current assets
Deposits with suppliers	$ 13.4	$ 9.4

XML

Assets - Property, Plant, and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Property, plant, and equipment
Gross property, plant and equipment	$ 290,984		$ 290,984		$ 279,556
Less: accumulated depreciation and amortization	178,991		178,991		172,275
Net property, plant, and equipment	111,993		111,993		107,281
Depreciation expense	4,000	$ 4,000	8,200	$ 7,700
Land
Property, plant, and equipment
Gross property, plant and equipment	5,061		5,061		5,061
Building and improvements
Property, plant, and equipment
Gross property, plant and equipment	64,151		64,151		64,198
Machinery and equipment
Property, plant, and equipment
Gross property, plant and equipment	166,764		166,764		155,533
Leaseholds improvements
Property, plant, and equipment
Gross property, plant and equipment	$ 55,008		$ 55,008		$ 54,764

XML

Assets - Goodwill (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Changes in goodwill balances
Gross carrying amount, beginning balance	$ 430,331
Acquisition	33,021
Gross carrying amount, ending balance	463,352
Accumulated impairment	248,388	$ 248,388
Net amount, beginning balance	181,943
Net amount, ending balance	$ 214,964

XML

Assets - Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Intangible assets
Gross Carrying Amount, Intangible assets	$ 537,509	$ 508,969
Accumulated Amortization and Impairment, Intangible assets	489,317	485,082
Total Net Intangible Assets	48,192	23,887
Technology
Intangible assets
Gross Carrying Amount, Intangible assets	355,928	327,908
Accumulated Amortization and Impairment, Intangible assets	319,420	316,918
Total Net Intangible Assets	36,508	10,990
Customer relationship
Intangible assets
Gross Carrying Amount, Intangible assets	146,925	146,465
Accumulated Amortization and Impairment, Intangible assets	136,528	135,415
Total Net Intangible Assets	10,397	11,050
Trademarks and tradenames
Intangible assets
Gross Carrying Amount, Intangible assets	30,910	30,910
Accumulated Amortization and Impairment, Intangible assets	29,666	29,063
Total Net Intangible Assets	1,244	1,847
Other Intangible Assets
Intangible assets
Gross Carrying Amount, Intangible assets	3,746	3,686
Accumulated Amortization and Impairment, Intangible assets	3,703	$ 3,686
Total Net Intangible Assets	$ 43

XML

Liabilities - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Accrued expenses and other current liabilities
Payroll and related benefits	$ 21,358	$ 30,044
Contingent consideration	9,791
Warranty	8,577	8,601
Operating lease liabilities	3,615	3,333
Interest	1,351	2,853
Professional fees	3,443	2,102
Sales, use, and other taxes	2,708	2,027
Other	10,980	7,071
Total accrued expenses and other current liabilities	$ 61,823	$ 56,031

XML

Liabilities - Warranty (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2023 USD ($)
Warranty
Warranty period	1 year
Balance, beginning of the period	$ 8,601
Warranties issued	3,084
Addition from Epiluvac acquisition	49
Consumption of reserves	(3,484)
Changes in estimate	327
Balance, end of the period	$ 8,577

XML

Liabilities - Customer Deposits and Deferred Revenue (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Liabilities
Customer deposits	$ 136,600	$ 110,200
Changes in deferred revenue
Beginning balance	16,990
Deferral of revenue	8,241
Recognition of unearned revenue	(5,111)
Ending balance	$ 20,120

XML

Liabilities - Performance Obligations Amount (Details) $ in Millions	6 Months Ended
	Jun. 30, 2023 USD ($)
Performance obligations
Remaining performance obligations	$ 274.8
Minimum
Performance obligations
Performance obligation at time of contract origination	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01
Performance obligations
Percentage of remaining performance obligation expected to be recognized	66.00%

XML

Liabilities - Performance Obligations Timing (Details)	6 Months Ended
	Jun. 30, 2023
Liabilities
Revenue, Practical Expedient, Remaining Performance Obligation	true
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01
Performance obligations
Remaining performance obligations, expected timing of satisfaction	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01 | Minimum
Performance obligations
Remaining performance obligations, expected timing of satisfaction	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01 | Maximum
Performance obligations
Remaining performance obligations, expected timing of satisfaction	3 years

XML

Liabilities - 2023, 2025, 2027 and 2029 Convertible Senior Notes (Details) - USD ($) $ in Thousands, shares in Millions						6 Months Ended
	May 19, 2023	Nov. 05, 2021	Nov. 11, 2020	May 18, 2020	Jan. 10, 2017	Jun. 30, 2023	Dec. 31, 2022	Nov. 17, 2020
Debt
Principal amount						$ 281,500	$ 277,673
Proceeds from issuance of Notes, net of issuance cost						223,202
Cash paid for repurchase of notes						218,991
2023 Notes
Debt
Principal amount					$ 345,000		20,173
Interest rate (as a percent)					2.70%
Proceeds from issuance of Notes, net of issuance cost					$ 335,800
Repurchased and retired amount		$ 111,500	$ 125,000	$ 88,300
Carrying amount of debt extinguished		105,500	$ 113,100	78,100
Cash paid for repurchase of notes		115,600		81,200
Accrued and unpaid interest		$ 1,000
2025 Notes and 2027 Notes
Debt
Repurchased and retired amount	$ 198,800
2025 Notes
Debt
Principal amount						26,500	132,500	$ 132,500
Interest rate (as a percent)								3.50%
Repurchased and retired amount	106,000
Carrying amount of debt extinguished	105,400
Cash paid for repurchase of notes	$ 106,000
Number of shares of common stock used for repurchase of notes	0.7
Loss on extinguishment of debt	$ 16,500
2027 Notes
Debt
Principal amount				$ 125,000		25,000	$ 125,000
Interest rate (as a percent)				3.75%
Proceeds from issuance of Notes, net of issuance cost				$ 121,900
Repurchased and retired amount	100,000
Carrying amount of debt extinguished	98,500
Cash paid for repurchase of notes	$ 92,800
Number of shares of common stock used for repurchase of notes	3.8
Purchase of capped calls				$ 10,300
Loss on extinguishment of debt	$ 80,600
2029 Notes
Debt
Principal amount	$ 230,000					$ 230,000
Interest rate (as a percent)	2.875%
Proceeds from issuance of Notes, net of issuance cost	$ 223,200

XML

Liabilities - Convertible Senior Notes (Details)					3 Months Ended	6 Months Ended
	May 19, 2023 USD ($) $ / shares	Nov. 17, 2020 USD ($) $ / shares	May 18, 2020 USD ($) $ / shares	Jan. 10, 2017 USD ($)	Jun. 30, 2023 D	Jun. 30, 2023 USD ($) D
Convertible Notes
Debt
Multiples of principal holders may convert						1,000
Minimum threshold period | D						20
Consecutive trading days | D					30	30
Stock price trigger (as a percent)					130.00%	130.00%
Trading days | D						5
Number of consecutive business days						5 days
Maximum percentage of common stock conversion						98.00%
2023 Notes
Debt
Transaction costs				$ 9,200,000
2025 Notes
Debt
Conversion rate		0.0416667
Conversion price (in dollars per share) | $ / shares		$ 24.00
Transaction costs		$ 1,900,000
2027 Notes
Debt
Conversion rate			0.0715372
Conversion price (in dollars per share) | $ / shares			$ 13.98
Transaction costs			$ 3,100,000
2029 Notes
Debt
Conversion rate	0.03421852
Conversion price (in dollars per share) | $ / shares	$ 29.22
Transaction costs	$ 6,800,000

XML

Liabilities - Convertible Senior Notes Carrying Value (Details) - USD ($) $ in Thousands	Jun. 30, 2023	May 19, 2023	Dec. 31, 2022	Nov. 17, 2020	May 18, 2020	Jan. 10, 2017
Debt
Principal amount	$ 281,500		$ 277,673
Unamortized debt discount/transaction costs	(7,165)		(3,013)
Net carrying value	274,335		274,660
2023 Notes
Debt
Principal amount			20,173			$ 345,000
Unamortized debt discount/transaction costs			(4)
Net carrying value			20,169
2025 Notes
Debt
Principal amount	26,500		132,500	$ 132,500
Unamortized debt discount/transaction costs	(149)		(990)
Net carrying value	26,351		131,510
2027 Notes
Debt
Principal amount	25,000		125,000		$ 125,000
Unamortized debt discount/transaction costs	(358)		(2,019)
Net carrying value	24,642		$ 122,981
2029 Notes
Debt
Principal amount	230,000	$ 230,000
Unamortized debt discount/transaction costs	(6,657)
Net carrying value	$ 223,343

XML

Liabilities - Convertible Senior Notes - Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Non-Cash Interest Expense
Amortization of debt discount/transaction costs			$ 514	$ 477
Total Interest Expense	$ 2,523	$ 2,706	5,103	5,410
2023 Notes
Cash Interest Expense
Coupon interest expense		136	23	272
Non-Cash Interest Expense
Amortization of debt discount/transaction costs		24	4	48
2025 Notes
Cash Interest Expense
Coupon interest expense	737	1,159	1,896	2,318
Non-Cash Interest Expense
Amortization of debt discount/transaction costs	$ 77	114	$ 194	226
Convertible Debt, Fair Value by Fair Value Hierarchy Level	Level 2		Level 2
Estimated fair value	$ 31,900		$ 31,900
2027 Notes
Cash Interest Expense
Coupon interest expense	745	1,172	1,917	2,344
Non-Cash Interest Expense
Amortization of debt discount/transaction costs	$ 70	$ 101	$ 175	$ 202
Convertible Debt, Fair Value by Fair Value Hierarchy Level	Level 2		Level 2
Estimated fair value	$ 49,300		$ 49,300
2029 Notes
Cash Interest Expense
Coupon interest expense	753		753
Non-Cash Interest Expense
Amortization of debt discount/transaction costs	141		141
Estimated fair value	$ 257,000		$ 257,000

XML

Liabilities - Capped Call Transactions (Details) - Capped Call Transactions $ / shares in Units, $ in Millions	May 13, 2020 USD ($) $ / shares
Debt
Aggregate price of capped call transaction | $	$ 10.3
Cap price of the capped call transactions (in dollars per share) | $ / shares	$ 18.46

XML

Liabilities - Revolving Credit Facility (Details) - USD ($) $ in Millions		6 Months Ended	12 Months Ended
	Dec. 16, 2021	Jun. 30, 2023	Dec. 31, 2022
Credit Facility
Debt
Borrowing capacity	$ 150
Debt instrument term	5 years
Additional increase in borrowing subject to certain conditions	$ 75
Outstanding amount		$ 0	$ 0
Credit Facility | Minimum
Debt
Unused commitment fee percentage (as a percent)	0.25%
Interest coverage ratio	3.00
Credit Facility | Maximum
Debt
Unused commitment fee percentage (as a percent)	0.35%
Total net leverage ratio	4.50
Secured net leverage ratio	2.50
Credit Facility | Base rate | Minimum
Debt
Basis spread on base rate (as a percent)	0.50%
Credit Facility | Base rate | Maximum
Debt
Basis spread on base rate (as a percent)	1.25%
Credit Facility | SOFR
Debt
Floor rate on debt instrument (as a percent)	0.00%
Credit Facility | SOFR | Minimum
Debt
Basis spread on base rate (as a percent)	1.50%
Credit Facility | SOFR | Maximum
Debt
Basis spread on base rate (as a percent)	2.25%
Credit Facility, Letter of Credit
Debt
Borrowing capacity	$ 15

XML

Liabilities - Other Liabilities (Details) - Other liabilities - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Other liabilities
Medical and dental benefits	$ 1.9	$ 2.0
Asset retirement obligations	0.9	$ 0.7
Contingent consideration	$ 16.6

XML

Commitments and Contingencies - Lease terms (Details)	Jun. 30, 2023
Leases
Lease renewal term	5 years
Remaining lease term	12 years
Weighted average discount rate (as a percent)	5.60%

XML

Commitments and Contingencies - Minimum lease commitments (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Minimum lease commitments, Payments due by period:
2023	$ 1,748
2024	4,599
2025	4,086
2026	4,060
2027	3,629
Thereafter	34,245
Total future minimum lease payments	52,367
Less: Imputed interest	(15,914)
Total operating lease liabilities	36,453
Operating lease liability, current	$ 3,615	$ 3,333
Operating Lease, Liability, Current, Statement of Financial Position	Accrued expenses and other current liabilities
Long-term operating lease liabilities	$ 32,838	$ 33,581
Total operating lease liabilities	$ 36,453
Operating Lease, Liability, Statement of Financial Position	Long-term operating lease liabilities, Accrued expenses and other current liabilities

XML

Commitments and Contingencies - Lease costs (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Lease cost
Operating lease cost	$ 1.2	$ 1.8	$ 2.6	$ 3.7
Variable lease cost	$ 0.2	$ 0.5	0.5	1.0
Operating cash flows from operating leases			$ 3.0	$ 3.8

XML

Commitments and Contingencies - Receivable Purchase Agreement (Details) $ in Millions	3 Months Ended
	Jun. 30, 2023 USD ($)
Commitments and Contingencies
Maximum amount of trade receivables to be sold under agreement	$ 20.0
Receivables sold	9.9
Amount of trade receivables available to be sold under agreement	$ 10.1

XML

Commitments and Contingencies - Purchase Commitments and Bank Guarantees (Details) $ in Millions	Jun. 30, 2023 USD ($)
Purchase commitments
Purchase commitments due within one year	$ 235.5
Bank guarantees
Bank guarantees and letters of credit outstanding	19.3
Unused bank guarantees and letters of credit	$ 12.6

XML

Equity - Statement of Stockholders' Equity (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period	$ 585,559	$ 577,824	$ 403,570	$ 437,628	$ 577,824	$ 437,628
Net Income (Loss)	(85,320)	8,741	9,655	13,330	(76,579)	22,985
Other comprehensive income (loss), net of tax	(39)	476	(272)	(822)
Share-based compensation expense	7,932	7,027	6,278	4,481
Partial extinguishment of 2025 and 2027 Notes	102,140
Net issuance under employee stock plans	2,328	(8,509)	1,506	(6,787)
Balance at the end of the period	612,600	585,559	420,737	403,570	612,600	420,737
Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period				(44,260)		(44,260)
Common Stock
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period	$ 517	$ 517	$ 513	$ 507	$ 517	$ 507
Balance (in shares)	51,693	51,660	51,243	50,653	51,660	50,653
Partial extinguishment of 2025 and 2027 Notes	$ 45
Partial extinguishment of 2025 and 2027 Notes (in shares)	4,460
Net issuance under employee stock plans	$ 2		$ 2	$ 6
Net issuance under employee stock plans (in shares)	185	33	182	590
Balance at the end of the period	$ 564	$ 517	$ 515	$ 513	$ 564	$ 515
Balance (in shares)	56,338	51,693	51,425	51,243	56,338	51,425
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period	$ 1,076,698	$ 1,078,180	$ 1,057,808	$ 1,116,921	$ 1,078,180	$ 1,116,921
Share-based compensation expense	7,932	7,027	6,278	4,481
Partial extinguishment of 2025 and 2027 Notes	102,095
Net issuance under employee stock plans	2,326	(8,509)	1,504	(6,793)
Balance at the end of the period	1,189,051	1,076,698	1,065,590	1,057,808	1,189,051	1,065,590
Additional Paid-in Capital | Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period				(56,801)		(56,801)
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period	(493,060)	(501,801)	(655,412)	(681,283)	(501,801)	(681,283)
Net Income (Loss)	(85,320)	8,741	9,655	13,330
Balance at the end of the period	(578,380)	(493,060)	(645,757)	(655,412)	(578,380)	(645,757)
Accumulated Deficit | Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period				12,541		12,541
Accumulated Other Comprehensive Income
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period	1,404	928	661	1,483	928	1,483
Other comprehensive income (loss), net of tax	(39)	476	(272)	(822)
Balance at the end of the period	$ 1,365	$ 1,404	$ 389	$ 661	$ 1,365	$ 389

XML

Equity - AOCI Rollforward (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Changes in the balances of each component of AOCI
Balance at the beginning of the period	$ 585,559	$ 403,570	$ 577,824	$ 437,628
Other comprehensive income (loss)	(39)	(272)	437	(1,094)
Balance at the end of the period	612,600	420,737	612,600	420,737
Accumulated Other Comprehensive Income
Changes in the balances of each component of AOCI
Balance at the beginning of the period	1,404	661	928	1,483
Other comprehensive income (loss)			437
Balance at the end of the period	1,365	$ 389	1,365	$ 389
Foreign Currency Translation
Changes in the balances of each component of AOCI
Balance at the beginning of the period			1,773
Other comprehensive income (loss)			(33)
Balance at the end of the period	1,740		1,740
Unrealized Gains (Losses) on Available for Sale Securities
Changes in the balances of each component of AOCI
Balance at the beginning of the period			(845)
Other comprehensive income (loss)			470
Balance at the end of the period	$ (375)		$ (375)

XML

Share-based Compensation - Recognized Share-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Recognized share-based compensation
Total share-based compensation expense	$ 7,932	$ 6,278	$ 14,959	$ 10,759
Restricted stock | Minimum
Share-based compensation
Expiration term			1 year
Restricted stock | Maximum
Share-based compensation
Expiration term			4 years
Cost of sales
Recognized share-based compensation
Total share-based compensation expense	1,572	1,251	$ 3,023	2,189
Research and development
Recognized share-based compensation
Total share-based compensation expense	2,568	1,863	4,657	3,120
Selling, general and administrative
Recognized share-based compensation
Total share-based compensation expense	$ 3,792	$ 3,164	$ 7,279	$ 5,450

XML

Share-based Compensation - Stock Option Activity (Details) shares in Thousands	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Number of Shares
Outstanding at the beginning of the period (in shares) | shares	177
Expired (in shares) | shares	(62)
Outstanding at the end of the period (in shares) | shares	115
Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share) | $ / shares	$ 30.94
Expired (in dollars per share) | $ / shares	30.47
Outstanding at the end of the period (in dollars per share) | $ / shares	$ 31.18

XML

Share-based Compensation - Restricted shares and performance shares (Details) - Non-vested restricted shares and performance shares shares in Thousands	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Number of Shares
Outstanding at the beginning of the period (in shares) | shares	2,496
Granted (in shares) | shares	1,076
Performance award adjustments (in shares) | shares	183
Vested (in shares) | shares	(1,113)
Forfeited (in shares) | shares	(50)
Outstanding at the end of the period (in shares) | shares	2,592
Weighted Average Grant Date Fair Value
Outstanding at the beginning of the period (in dollars per share) | $ / shares	$ 23.83
Granted (in dollars per share) | $ / shares	22.79
Performance award adjustments (in dollars per share) | $ / shares	10.59
Vested (in dollars per share) | $ / shares	16.47
Forfeited (in dollars per share) | $ / shares	28.01
Outstanding at the end of the period (in dollars per share) | $ / shares	$ 25.66

XML

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Tax reconciliation disclosures
Income (loss) before income taxes	$ (84,035)	$ 10,188	$ (75,031)	$ 23,902
Income tax expense (benefit)	$ 1,285	$ 533	$ 1,548	$ 917
Effective tax rate (as a percent)	(1.53%)	5.23%	(2.06%)	3.84%
Loss on extinguishment of convertible notes, tax benefit	$ 900		$ 900

XML

Segment Reporting and Geographic Information (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) segment item	Jun. 30, 2022 USD ($)
Revenue reporting by end-market and geographic region
Number of operating segments | segment			1
Number of reportable segments | segment			1
Number of end-markets | item			4
Sales	$ 161,641	$ 163,999	$ 315,145	$ 320,425
UNITED STATES
Revenue reporting by end-market and geographic region
Sales	35,739	57,940	66,750	105,410
EMEA
Revenue reporting by end-market and geographic region
Sales	17,511	27,234	40,458	48,660
China
Revenue reporting by end-market and geographic region
Sales	49,986	28,497	110,733	58,878
Rest of APAC
Revenue reporting by end-market and geographic region
Sales	58,320	49,345	97,065	106,267
Rest Of World
Revenue reporting by end-market and geographic region
Sales	85	983	139	1,210
Semiconductor
Revenue reporting by end-market and geographic region
Sales	106,275	97,521	199,382	175,141
Compound Semiconductor
Revenue reporting by end-market and geographic region
Sales	24,066	31,122	45,225	68,231
Data Storage
Revenue reporting by end-market and geographic region
Sales	13,945	21,548	35,459	43,143
Scientific & Other
Revenue reporting by end-market and geographic region
Sales	$ 17,355	$ 13,808	$ 35,079	$ 33,910

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ (85,320)	$ 8,741	$ 9,655	$ 13,330	$ (76,579)	$ 22,985

XML

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false